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Abstract 
Peroxisome proliferator-activated receptors (PPARs) are nuclear transcription 
factors eliciting a variety of cellular responses by regulating a combination of target 
genes. Among the three isoforms, PPARa, PPARp/a and PPARy, PPARa is 
well-characterized to play important roles in lipid metabolism, as well as induction of 
liver cancer when activated by peroxisome proliferators such as Wy-14,643 
([4-chloro-6(2,3-xylidino)-2-pyrimidinylthio]acetic acid), clofibrate and plasticizers. 
A novel PPARa target gene - PPARa-regulated and Starvation Inducible Gene 
(PPSIG) was identified by fluorescent differential display in our laboratory. Its 
functions remain elusive while it shows sequence homology to phytoene 
dehydrogenase and is recently found to be a saturase. PPSIG is constitutively 
expressed in liver and its expression is dramatically induced by both 72-h starvation 
and 2-wk treatment with Wy-14,643 in PPARa wild-type mice but not in PPARa 
knockout mice. Open reading frame analysis suggests that PPSIG is a � 6 7 kDa 
protein. According to computer-assisted prediction and confocal microscopic 
observation of mammalian cells transiently over-expressing GFP-PPSIG fusion 
proteins, PPSIG is localized in the endoplasmic reticulum. 
i 
As PPSIG is a novel PPARa target gene, characterization of its function and 
biological role will be of high scientific significance. To start with, we investigated 
its subcellular localization and protein induction level in mouse liver. In order to 
identify the PPSIG protein in Western blottings，antibody specific to PPSIG was 
produced. A truncated length of PPSIG cDNA was first cloned into two prokaryotic 
expression vectors, pThioHis and pTYB and transformed into E. coli for the 
production of two recombinant proteins having different fusion partners. In order to 
minimize bacterial contaminants, the fusion proteins were semi-purified by cutting 
out the protein band from a preparative SDS-PAGE gel. Rabbits were immunized 
with 5 boostings of homogenized protein bands containing the fusion protein antigens. 
Using the polyclonal antisera obtained as primary antibodies in Western blottings of 
subcellular fractions, PPSIG was detected as a � 6 7 kDa protein localized primarily in 
the endoplasmic reticulum. The native PPSIG was immimoprecipitated from liver 
microsomes by the antiserum and identified by mass spectrometry. PPSIG protein 
induction analysis using liver microsomes showed that it was highly induced by 72-h 
starvation but only slightly induced by 2-wk Wy-14,643 treatment. The 
differentiated protein induction pattern suggested that starvation is more likely the 
physiological inducer of PPSIG protein, with the implication that PPSIG plays more a 
biological role than a toxicological role in mouse liver. The findings inevitably 
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Chapter 1 Introduction 
1.1 Peroxisome proliferator-activated receptors 
(PPARs) 
1.1.1 What are PPARs? 
PPARs belong to the nuclear hormone receptor superfamily, which also 
includes receptors for retinoic acid, thyroid hormone and estrogen. They are single 
polypeptide proteins with a variable amino-terminal domain, a highly conserved 
DNA-binding domain and a carboxyl-terminal ligand-binding domain (Ribeiro et al 
1995). They are regulated by exogenous and endogenous ligands known as 
peroxisome proliferators (PPs), which bind to the receptor and activates its 
translocation to the nucleus. After formation of a heterodimer with 9-cz5-retinoid X 
receptor (RXR), PPARs bind to their corresponding responsive elements and regulate 
the expression of their target genes by either inducing or inhibiting their transcription 
(Reddy and Hashimoto 2001). 
1.1.2 PPAR ligands 一 peroxisome proliferators 
Peroxisome proliferators are a diverse group of chemicals that causes 
peroxisome proliferation in rodent liver, characterized by liver enlargement due to 
1 
hyperplasia and hypertrophy (Dzhekova-Stojkova et al 2001). A group of potent 
peroxisome proliferators was hypolipidemic drugs, e.g. Wy-14,643, clofibrate and 
ciprofibrate (Lock et al 1989). Besides hypolipidemic drugs, plasticizers such as 
diethylhexyl phthalate also causes certain extent of peroxisome proliferation. Other 
PPs include environmental contaminants, e.g. herbicides, industrial solvents and food 
flavours (Dzhekova-Stojkova et al 2001). Structure of PPs usually consists of a 
carboxylic functional group and a large hydrophobic domain, which is similar to fatty 
acids. In fact, fatty acids are endogenous PPs that can be induced under various 
physiological conditions such as starvation, high fat diets and diabetes mellitus 
(Vanden Heuvel 1999). Starvation usually causes differential expression of 
peroxisomal enzymes in similar manner to exogenous PPs (Leone et al. 1999). 
1.1.3 PPAR isoforms 
PPARs exist in three isoforms, PPARa, PPARp/a and PPARy. Encoded by 
different genes, they exhibit different tissue distribution and function. PPARa is 
predominantly expressed in liver and intestine and participates actively in energy 
metabolism (Ehrmann et al 2002; Reddy and Hashimoto 2001). PPARp/a is 
expressed at a slightly higher level in intestine than in liver and spleen (Ehrmann et al 
2002). Its physiological role is relatively less characterized, but it has been found to 
2 
induce differentiation of epithelial cells while inhibiting cell proliferation (Burdick et 
al 2006; Michalik et al 2003). PPARy is localized mostly in adipocytes and is also 
found in spleen and intestine (Ehrmann et al 2002). It plays an important role in 
adipocyte differentiation and takes part in insulin sensitization, anti-inflammatory and 
anti-atherogenic effects (Haag and Dippenaar 2005; Lehrke and Lazar 2005; Madsen 
et al 2005; Racke et al 2006; Pineda Torra et al. 1999). Although the three PPAR 
isoform differ in ligand specificity and tissue distribution, their physiological roles are 
interrelated, accounting for their pleiotropic effects. 
1.2 Biological roles of PPARa 
1.2.1 Lipid metabolism 
Extensive studies have focused on the role of PPARa on lipid metabolism. A 
number of PPARa target genes have been identified to play important roles in fatty 
acid uptake and p-oxidation in mitochondria and peroxisomes (Mandard et al 2004). 
Acyl-CoA dehydrogenase in mitochondria oxidizes short to long chain fatty acids 
(Djouadi et al. 2005) while peroxisomes contains acyl-CoA oxidase that oxidizes very 
long chain fatty acids (Chu et al 1995). During starvation, PPARa masters the 
change in energy source by regulating the expression of cytochrome P450 4A 
enzymes involved in microsomal fatty acids co-hydroxylation (Kroetz et al 1998) and 
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mitochondrial 3-hydroxy-3-methylglutaryl-CoA (mHMG-CoAS), a rate-limiting 
enzyme in ketogenesis (Rodriguez et al 1994). As a counter effect to fatty acid 
oxidation, PPARa was also reported to induce lipogenesis by upregulate a number of 
lipogenic enzymes, e.g. stearoyl-CoA desaturase-1 (SCD-1) and long chain free fatty 
acid elongase, a possible feedback mechanism to prevent excessive fatty acids 
breakdown (Zhou et al 2006). In addition, it promotes plasma HDL and triglyceride 
clearance by upregulating the expression of apolipoproteins (Edvardsson et al. 2006) 
and help excretion of fatty acid by mediating hepatic bile acid metabolism (Barbier et 
al 2003) 
1.2.2 Glucose metabolism 
PPARa plays a more important role in glucose metabolism during deprivation 
of glucose. It is thought to prevent decreased plasma glucose level by activating 
pathways for glucose production, as hypoglycemia is observed in PPARa knockout 
mice (Chakravarthy et al 2005). During early stage of starvation, PPARa is 
believed to cause hepatic glycogen breakdown although no target gene has been 
identified. It also down-regulates the activity of phosphoenol-pyruvate 
carboxykinase that is responsible for gluconeogenesis (Srivastava et al 2006). In 
addition, it reduces the utilization of glucose through glycolysis by activating 
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pyruvate dehydrogenase kinase isoform 4 (Sugden et al 2001). 
1.2.3 Inflammation 
Although not as potent as PPARy, PPARa exerts a certain effect on inhibiting 
inflammation, usually through trans-repression of related genes (Mandard et al 2004). 
PPARa activation down-regulates the expression of endothelin-I, vascular cell 
adhesion molecule 1 (VCAM-1), IL-6 and cyclooxygenase-2 (Dyroy et al 2005; 
Mandard et al 2004; Pineda Torra et al 1999; Racke et al 2006; Zambon et al 2006). 
By inhibiting the production of cytokines and growth factors, it inactivates endothelial 
cells, smooth muscle cells and macrophages, which are responsible for inflammatory 
response. 
1.2.4 Oxidative stress 
During fatty acid oxidation, the reaction catalyzed by the PPARa target gene 
acyl-CoA oxidase generates reactive intracellular peroxide (H2O2) molecules that can 
lead to cell damage. Accumulation of peroxide in cells results in oxidative stress, 
but it is inconclusive whether the level of oxidative stress produced by PPARa is 
enough to cause oxidative damage to macromolecules (Bosgra et al 2005; Peters et al. 
2005). 
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1.2.5 Cell proliferation and apoptosis 
The mechanism of PPARa-mediated cell proliferation and apoptosis are not 
fully known, but may be contributed by the generation of intracellular free radicals 
(Bosgra et al. 2005; Peters et al. 2005). Studies have shown that the induction of 
DNA synthesis and suppression of apoptosis by peroxisome proliferators required 
tumour necrosis factor alpha receptor 1 (TNFa-1) and interleukin 1 (IL-1) receptor 
through the activation of MAK kinase signaling pathway. (Cosulich et al. 2000; 
Hasmall et al 2000; West et al 1999). 
1.3 PPARa in health and diseases 
1.3.1 Wound-healing 
Activation of PPARa reduces apoptosis and lessens the extent of tissue injury. 
It inhibits proliferation of endothelial cells and macrophages, which causes 
inflammation. Activation of PPARa by its ligand lengthens the time to produce an 
inflammatory response, thereby giving more time for tissue recovery (Dyroy et al 
2005). PPARa is transiently induced after injury and it ligands have shown 
protective effect in injured kidney, intestine and lung (Michalik and Wahli 2006). 
The extent of tissue injury after ischemia/reperfusion was greater in PPARa knockout 
mice than wild-type mice. 
6 
1.3.2 Anti-atherogenesis 
Early stage of atherosclerosis involves expression ofVCAM-1 that plays a 
role in monocytes recruitment to atherosclerosis lesions. Monocytes, when activated 
by monocyte chemoattractant protein-1 (MCP-1) and interleukin 8 (IL-8), will 
differentiate into macrophages and form foam cells that eventually lead to plaques. 
By inhibiting cytokine expression and macrophage proliferation, PPARa helps 
prevent atherogenesis (Lefebvre et al. 2006; Pineda Torra et al. 1999). 
1.3.3 Neuroprotection 
PPARa was shown to preventively protect the brain from cerebral ischemia. 
Activation of PPARa improves sensitivity to endothelial relaxation, regulates 
oxidative stress by upregulating antioxidant enzymes, and decreases VCAM-1 and 
intercellular adhesion molecule 1 (ICAM-1) expression. The PPARa-dependence of 
the neuroprotective effect is yet to be confirmed and independent of PPARa's role in 
lipid metabolism (Deplanque et al. 2003). 
1.3.4 Carcinogenesis 
Long term treatment of Wy-14,643，a potent PPARa ligand, produced 100% 
incidence of liver cancer in PPARa wild-type but not knockout mice. Oxidative 
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stress is being considered a major cause for carcinogenesis because of its devastating 
ability. Free radicals produced can easily get into nucleus and induce DNA mutation 
(Bosgra et al 2005). These free radicals activate the oxidative signaling pathway in 
parallel, which stimulates cell proliferation and inhibits apoptosis. It inhibits the 
programmed death of cells containing DNA with undesirable mutation. If these cells 
are further stimulated to replicate, they will soon be transformed into carcinoma 
(Peters et al. 2005). 
The diverse effect of PPARa suggests that it plays a pivotal role in many 
important pathways, with the orchestration of different target genes. The 
identification of the whole spectrum of target genes will inevitably help unveiling the 
physiological and pharmacological role of PPARa. 
1.4 PPARa-regulated and starvation inducible 
gene (PPSIG) 
1.4.1 PPSIG is a PPARa target gene 
A � 5 8 0 bp cDNA fragment (D3#3) was found to display at higher level in 
PPARa wild-type mice starved for 72 h in a fluorescent differential display, 
performed with API and ARP3 primers (Lo, paper submitted). It was recovered 
from the gel, reamplified and used as a probe for Northern blotting using liver RNA 
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from PPARa wild-type and knockout mice either fed or starved for 72 h. The probe 
detected two transcripts at �2000 and -3000 bp, both showing a significantly higher 
expression level in wild-type mice starved for 72 h than the other three groups of mice 
(Ng, 2005). The same transcripts were detected with a higher expression level in 
wild-type but not knockout mice treated with Wy-14,643 for 11 months. As the gene 
can be induced by both PP and starvation, the gene was named PPARa-regulated and 
starvation inducible gene (PPSIG). The induction was only observed in PPARa 
wild-type but not knockout mice, further suggesting that PPSIG is a putative PPARa 
target gene. Recent discovery of a peroxisome proliferator responsive element 
(PPRE) in intron 1 (+375 to + 387) of PPSIG further supported its regulatory effect by 
PPARa (Ng, 2005). 
1.4.2 Computer-assisted predictions on PPSIG 
Full length of PPSIG mRNA was obtained from the FDD fragment by rapid 
amplification of cDNA ends (RACE). By submitting the mRNA sequence of PPSIG 
for BLAST searching, it was found to share 100% identity with RIKEN cDNA 
0610039N19 gene with accession number 87044905. As the RIKEN gene was a 
novel gene with unknown function, the translated PPSIG protein sequence was 
subjected to putative conserved domain analysis, and the protein was predicted to 
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belong to a family of phytoene dehydrogenase having a domain with amino oxidase 
activity. Protein sequence analysis using TMHMM2.0 software showed that PPSIG 
may have a transmembrane segment containing amino acid residues 5-27. 
Subcellular localization prediction by WoLF PSORT software also showed that 
PPSIG is a membrane-bound protein localized in the endoplasmic reticulum. For 
signal peptide analysis using Signal? 3.0 Server, PPSIG is predicted to contain a 
secretary signal peptide with residues 1-25, which may be cleaved off upon secretion. 
1.4.3 Current characterization of PPSIG 
In 2004, a group of researchers working on retinoids identified the RIKEN 
gene as o^Urans-13,14-dihyroretinol saturase (RetSat) (Moise et al 2004). RetSat 
was reported to catalyze the in vitro conversion of all-rraw^-retinol to 
a\\-trans-13,14-dihydroretinol with no PPARa dependence described and biological 
role yet unknown. PPSIG mRNA has a high constitutive expression level in liver, 
kidney, small intestine, white fat and brown fat and can be induced in different organs, 
markedly in liver and kidney (Lo, 2003). It was found to localize in the endoplasmic 
reticulum by observing the compartmentation of GFP-PPSIG fusion protein in 
mammalian cells (Sun, paper submitted). 
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1.5 Objectives of the present study 
PPSIG is at present a novel PPARa target gene. Further characterization 
such as proteomics and functional studies will be needed to unveil its biological role. 
In order to identify of PPSIG protein from tissue samples, the current study aims to 
produce a polyclonal antiserum immunogenic to PPSIG. 
The project includes several objectives: 
(1) To clone a partial length of PPSIG into pThioHis and pTYB expression 
vectors for the expression of Thio-PPSIG and Intein-PPSIG fusion 
proteins, 
(2) To immunize rabbits with the PPSIG fusion protein antigens for generation 
of polyclonal antisera, 
(3) To test for antigenicity of the antisera against its bacterial recombinant 
antigen on Western blottings, 
(4) To identify the native PPSIG from liver microsomes assisted by protein 
induction by starvation and Wy-14,643 in PPARa wild-type and knockout 
mice, 
(5) To confirm the native PPSIG by mass spectrometry followed by 
immunoprecipitation. 
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Chapter 2 Materials and Methods 
2.1 Materials 
Wy-14,643 was purchased from Chemsyn Science Laboratories (Lenexa, KS, 
USA). Mouse chows containing 0.0% or 0.1% (w/w) Wy-14,643 were produced by 
Bioserv Company (Frenchtown, NJ, USA). 100 bp and 1 kb DNA ladders, 
BenchmarkTM prestained protein ladder, polyclonal anti-PMP70 antibody and 
monoclonal anti-thio antibody were obtained from Invitrogen (Carlsbad, CA, USA). 
Nuclease-free water (NF water) and supercoiled DNA ladder was obtained from 
Promega (Madison, WI, USA). DIG-labeled RNA molecular weight marker I was 
purchased from Roche (Germany). SDS-PAGE natural standards. Kaleidoscope 
prestained standards and prestained standards were obtained from Bio-Rad 
Laboratories (Hercules, CA, USA). Restriction enzymes and polyclonal anti-(chitin 
binding domain) antiserum (anti-CBD) were purchased from New England Biolabs 
(Beverly, MA, USA). Bacto"™ tryptone and yeast extract were purchased from BD 
Biosciences (San Jose, CA, USA). Polyclonal anti-calnexin antibody and anti-cpnlO 
antibody were purchased from Stressgen (Ann Arbor, MI, USA). All other 
chemicals of the highest analytical grade were purchased from Sigma (St. Louis, MO, 
USA) and USB chemical (Cleveland, OH, USA). 
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2.2 Animals and treatment 
PPARa knockout mice generated on SV/129 background was obtained from 
the US National Cancer Institute (National Institutes of Health, Bethesda, MD, USA) 
« 
(Lee et al 1995). They were inbred and reared in the Laboratory Animal Services 
Centre of the Chinese University of Hong Kong together with PPARa wild-type mice 
(SV/129 mice) on a 12-h light/dark cycle. For starvation experiment, three-month 
old male PPARa wild-type and knockout mice were starved for 3 days while control 
group mice were fed with normal diet (Laboratory Diet™ brand mouse diet No. 5015, 
PMI Nutrition, St. Louis, MO). For treatment with Wy-14,643, mice were fed with 
mouse chow containing either 0.0% (control group) or 0.1% (w/w) Wy-14,643 for 2 
weeks. Mice were sacrificed by cervical dislocation. Their livers were collected 
and frozen immediately in liquid nitrogen. Half of each liver was used for total RNA 
extraction and half for preparation of microsomes. 
2.3 Cloning of PPSIG into pThioHis and pTYB 
expression vectors 
2.3.1 PCR amplification of PPSIG cDNA insert 
2.3.1.1 PPSIG cDNA insert for pThioHis vector 
PPSIG was cloned into a pThioHis C expression vector (Figure 2.1) using the 
13 
Sac II Xba I 
cloning site cloning site 
Thioredoxin \ / 
\ i / 
#pThioHis% 
1 vector J 
\ 4.4 kb W 
Figure 2.1 Map of pThioHis vector 
The pThioHis vector allowed the addition of the thioredoxin fusion partner at the 
N-terminal of PPSIG. The Sac II and Xba I digestion sites were chosen for cloning 
of PPSIG cDNA. 
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Invitrogen His-Patch ThioFusion Expression System (Carlsbad, CA, USA). A 
partial length of PPSIG inclusive of the stop codon was amplified from a RACE clone 
(5'II32) to produce a PGR product of 811 bp containingXba I and Sac II cloning sites 
using a forward primer 5, -TCCCCGCGGGGAATGCGGGAATGTTCAATAC-3, with 
a Sac II site (underlined) and a reverse primer 
5,-GCTCTAGAGCTTCTCTGAACGGACTACAT-3, with dJcvXba I site (underlined) 
(Figure 2.2). A 20 ng PPSIG cDNA, 10 jamole forward primer and 10 |amole reverse 
primer were added to a core mix containing IX PGR buffer, 2 mM magnesium 
chloride (MgS04)，0.1 mM dNTPs and 1 U Platinum Taq DNA polymerase 
(Invitrogen, Carlsbad, CA, USA), making up to 50 with NF water. The PGR 
reaction was performed for 35 cycles including a denaturing step at 94°C for 30 s, an 
annealing step at 54°C for 30 s and an extension step at 68°C for 2 min using a 
thermocycler (Applied Biosystem GeneAMP PCR 9700). DNA concentrations were 
measured by absorbance at 260 nm using a scanning spectrophotometer (Beckman 
DU640 UV-VIS-NIR). 
2.3.1.2 PPSIG cDNA insert for pTYB vector 
PPSIG was cloned into a second pTYBl expression vector (Figure 2.3) using 
the New England Biolabs Impact'^^-CN protein fusion and purification system 
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GCGGTCTTCCGAGCC CTGGCAGCAAG^JT GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 90 
GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGA 180 
AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 270 
CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGTGCTGGAAC AACATACCAAGGCGG GCGGCTGTTGTCATA CCTTTGGGGAAAATG 360 
GCCTTGAATTTGACA CTGGAATTCATTATA TTGGACGAATGCGGG AGGGCAACATTGGCC GTTTTATCTTGGACC AGATCACTGAAGGGC 450 
AACTGGACTGGGCCC CCATGGCCTCCCCTT TTGACTTGATGATAC TAGAAGGGCCCAATG GCCGAAAGGAGTTCC CCATGTACAGTGGGA 540 
GGAAAGAATACATCC AGGGCCTTAAGAAGA AGTTCCCCAAGGAAG AAGCTGTCATTGACA AGTACATGGAGTTGG TTAAGGTGGTGGCCC 630 
GTGGAGTCTCTCATG CAGTTCTACTCAAGT TCCTCCCATTGCCCT TGACTCAGCTCCTCA GCAAGTTTGGGCTAC TGACTCGTTTCTCTC 720 
CATTCTGCCGAGCGT CTACGCAGAGCCTAG CTGAAGTCCTGCAGC AGCTTGGGGCTTCCC GTGAGCTCCAGGCTG TTCTCAGCTACATCT 810 
TCCCCACTTACGGAG TAACTCCCAGCCACA CCGCCTTTTCCTTGC ATGCTCTGCTGGTTG ACCACTACATACAAG GGGCATATTACCCTC 900 
GAGGGGGTTCCAGTG AGATCGCCTTCCATA CCATCCCTTTGATTC AGCGGGCCGGGGGCG CTGTCCTCACCAGGG CCACTGTACAGAGTG 990 
Sac I I 
s i G - F P - s a c i i TCC|CCGCGG|GGA 
TGCTGCTGGACTCAG CTGGGAGAGCGTGTG GTGTCAGTGTGAAGA AGGGACAAGAGCTGG TGAACATCTACTGCC CAGTTGTCATCTCCA 1080 
ATGCGGOAATGTTCA ATAC 
ATGCGGGAATGTTCA ATACCTATCAGCACT TGTTGCCAGAGACTG TCCGCCATCTGCCAG ATGTGAAGAAGCAGC TGGCGATGGTAAGGC 1170 
CTGGTCTGAGCATGC TCTCAATCTTCATCT GTCTGAAAGGCACCA AGGAGGACCTGAAGC TTCAGTCCACCAACT ACTATGTTTATTTTG 1260 
ACACAGACATGGACA AAGCGATGGAGCGCT ATGTCTCTATGCCCA AGGAAAAGGCTCCAG AACACATTCCCCTTC TCTTCATTGCCTTCC 1350 
CATCAAGCAAGGATC CAACCTGGGAGGAGC GATTCCCAGACCGAT CCACAATGACTGCGC TGGTACCCATGGCCT TTGAATGGTTCGAGG 1440 
AGTGGCAGGAGGAGC CAAAGGGCAAGCGTG GTGTTGACTATGAGA CCCTCAAAAATGCCT TCGTGGAAGCCTCTA TGTCGGTGATCATGA 1530 
AACTGTTCCCACAGC TGGAGGGCAAGGTGG AGAGTGTGACTGGAG GGTCACCACTGACCA ACCAGTACTATCTGG CTGCACCCCGAGGAG 1620 
CTACCTATGGAGCTG ACCATGACTTGGCTC GGCTGCATCCTCATG CAATGGCTTCCATAA GAGCCCAAACCCCCA TCCCCAACCTCTACC 1730 
TGACAGGCCAAGATA TCTTCACCTGTGGGC TGATGGGGGCCCTGC AGGGGGCCTTGCTGT GCAGCAGTGCCATCC TGAAACGGAACTTGT 1800 
Xba I 
TACATCAGGC AAGTCTCTTCGt^GAT C ^ G S I G - R P - X b a l 
ACTCAGATCTGCAGG CTCTTGGCTCAAAGG TCAAGGCACAAAAGA AGAAGATGBBTCCG TTCAGAGAAGAGCCA GAGGAAAGGCACCTC 1890 
CCCAACTTCTCGTGG TGTCCTCCCTCCTAC AGCAATTCCTTGCAC ATATAAACAAAAACC ATTTTGTTTCTGATT AGTGTTGTTAAGTCA 1980 
AGAGTTCTTTACCTT GCATTCTACTTAAGG CCTAGTGTGAACTAC ATAGCCTTGATGCCT CATGAAGAATGCTCC CATGCCTTTCCTACA 2070 
CCCAACTCCAAGCTA TGGTCAGGCACCCAG AACCCCTGGGGTGTT GGCTACTGGAATAGG TTGGTTCAGTCCTAC CCTGAAGCTTTTTGT 2160 
TCCTCCTCACTCTCG TGTTGTGATGCTCTA TACATGGAAAAGTGT GGGCTTGGAGTAGCA ACTCTCTCAAAGTGC CAGACCTAAGAAAAC 2250 
CCTCAGGTCTAAGTT TTATCCTGATAGAAG TGGGTTAAAGGAACA CACCAAAAGATACCA CTGCCGATGAACCAA GCCTAGACACGGCAT 2340 
TTGTAGTTGCTGGCA CATAGTCAAACTGAG TTACGAGGCTGGGCA GTGCTGGCACCGGCC TTTAACCCCAGCACT CAGAAGGCAGGGGCA 24 30 
GACAGAGCTCTGTGA ATCTGAAGCCAGAAC TAGTTTATGAAGCAA GTCCAGGGCAGCCAG AGCTCTGTTATACAG AGAAACCCTGTCTTG 2520 
AAAAACAAAACAAGG CAAAACAAAACCTGA GTATTGTTTTCTAAA ATGCTTGGAGTCAGA ATTCTTTCAGATTTT GTAGTATTTGCATAC 2610 
ACATGAGATAACCTG GGGAATGGGTCCCAG AACTAAACCACAAAT TCATTTGTTTCATAT GTATAGACCAGGCAC AACATCTTATGTAAT 2700 
ACTTTGAAAAACTGA GCATTCTGACCTGTC ACATGAGTCCATGCT ATAATTTAAAAAGCT TGCTTTGATTTCAGA ATAGGGATGCTTTAC 2790 
CTATATGAGTAAATG AGAAGGTGGATAAAA ATTAAAAACCTTTCA CTTATGTTAAACAAG TGCTAATTTTAGTCT GTTTAAATATAGTAT 2680 
TAATACATGTAATGT TTCAA 2900 
Figure 2.2 Primer design for PCR amplification of PPSIG containing Xba I 
and Sac II sites for cloning into pThioHis vector 
A set of primers (highlighted in yellow) was designed to amplify a partial PPSIG 
cDNA of 811 bp，with the Sac II digestion site-containing forward primer located at 
1081 bp of the full length PPSIG cDNA and the Xba I site-containing reverse primer 
located at 1856 bp region inclusive of the stop codon of PPSIG (highlighted in blue). 
The start codon of the full length PPSIG was highlighted in red. 
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Chitin-binding domain 
Mfel 7225 P«t I 7330 
Age I 7150 \ \ BIp I 7393 
BfrB I - Nsi I 7133 \ \ \ / BspE I 7471 
Intein Btgi-sac" 7023 \ A \ \ / 
Pml I 7013 � \ ( { Pvul 555 
Sap I ^\BstBI 6960 yFspl 702 
cloning site ^ Bsai ass 
I Bgl II 6261^^ X N/^ 
/ Hind III 6230 \ Swn I 1096 
/ BsrGI 5915 � / 
/ Acc65 I - Kpn I 5788 \ / 巧 \ V ^ Dra III 1319 
L sre. 遍 ^ 
Pa»R7l-TIH-Xhol 5761 \ 
EcoRI 5755 MCS 
厂 “ [？ pTYB vector .、 
NnjI 5 7 3 4 / / / 在 Bmtl-Nh*! 6728 / Xba I 5683 / Nd«l 5722 / ' \ / % / Pmel 5606 \ / 
\ \ / Pcil 2310 
\ \ <0^  / ^ ^ BstZ17 丨 2480 
Nde I y v , 
cloning site econi 4562 
Mlul 4098 y y \ Afel 3194 
BstE II 3916 \ Kas I • Nar I - Sfo I 3459 
Apa I - PspOM I 3891 EcoR V 3650 
BssH II 3687 
Figure 2.3 Map of pTYB vector 
The pTYB vector allowed the addition of intein at the C-terminal of PPSIG. Chitin 
binding domain (CBD) is present at the C-terminal of intein to facilitate fusion protein 
detection by Western blotting. The Sap I and Nde I digestion sites were chosen for 
cloning of PPSIG cDNA. 
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(Beverly, MA, USA). The partial PPSIG was amplified by PCR to produce a cDNA 
of 792 bp using the same PCR mixture as described in section 2.3.1.1 except that 10 
l^mole each of a forward primer 
5 ’-GGTGGTCATATGTTCAATACCTATCAGCACT-3, with Nde I digestion site 
(underlined) and a reverse primer 
5,-GGTGGTTGCTCTTCCGCACATCTTCTTCTTTTGTGCCTTG-3, with Sap I site 
(underlined) were added (Figure 2.4). The forward primer contained the start codon, 
but the stop codon was excluded from the reverse primer so that transcription is 
attenuated after the intein and the chitin-binding domain. PCR reaction was 
performed for 30 cycles including a denaturing step at 94°C for 30 s, an annealing 
step at 65°C for 30 s and an extension step at 72°C for 2 min. 
2.3.2 Restriction enzyme digestion of PPSIG cDNA 
insert and pThioHis vector 
The PPSIG cDNA insert and the expression vector pThioHis C were 
double-digested with Xba I and Sac II. Digestion mixture of cDNA insert contained 
2 jig cDNA, 20 U Sac II, 20 Xba I, IX NEBuffer 2 and IX BSA added up to 40 |il 
with autoclaved distilled water. Digestion mixture of pThioHis vector contained 5 
}ig DNA, 60 U Sac II，60 Xba I, IX NEBuffer 2, IX BSA and autoclaved distilled 
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GCGGTCTTCCGAGCC CTGGCAGCAAC^^ GGATCACTGCTCTGC TGCTGGCCGTGCTGC TGCTGGTGATCCTCC ACAGGGTCTACGTGG 90 
GCCTTTACGCTGCAA GTTCCCCGAACCCCT TCGCCGAGGATGTCA AGCGACCGCCTGAAC CCCTGGTGACCGACA AGGAGGCTAGGAAGA 180 
AAGTTCTCAAACAAG CTTTCTCAGTCAGCC GAGTACCAGAGAAGC TGGATGCAGTGGTGA TCGGCAGCGGCATTG GGGGACTGGCCTCAG 270 
CTGCGGTTCTAGCTA AAGCTGGCAAGAGAG TCCTTGTGCTGGAAC AACATACCAAGGCGG GCGGCTGTTGTCATA CCTTTGGGGAAAATG 360 
GCCTTGAATTTGACA CTGGAATTCATTATA TTGGACGAATGCGGG AGGGCAACATTGGCC GTTTTATCTTGGACC AGATCACTGAAGGGC 450 
AACTGGACTGGGCCC CCATGGCCTCCCCTT TTGACTTGATGATAC TAGAAGGGCCCAATG GCCGAAAGGAGTTCC CCATGTACAGTGGGA 540 
GGAAAGAATACATCC AGGGCCTTAAGAAGA AGTTCCCCAAGGAAG AAGCTGTCATTGACA AGTACATGGAGTTGG TTAAGGTGGTGGCCC 630 
GTGGAGTCTCTCATG CAGTTCTACTCAAGT TCCTCCCATTGCCCT TGACTCAGCTCCTCA GCAAGTTTGGGCTAC TGACTCGTTTCTCTC 720 
CATTCTGCCGAGCGT CTACGCAGAGCCTAG CTGAAGTCCTGCAGC AGCTTGGGGCTTCCC GTGAGCTCCAGGCTG TTCTCAGCTACATCT 810 
TCCCCACTTACGGAG TAACTCCCAGCCACA CCGCCTTTTCCTTGC ATGCTCTGCTGGTTG ACCACTACATACAAG GGGCATATTACCCTC 900 
GAGGGGGTTCCAGTG AGATCGCCTTCCATA CCATCCCTTTGATTC AGCGGGCCGGGGGCG CTGTCCTCACCAGGG CCACTGTACAGAGTG 990 
S I G - F P - N d e l G 
TGCTGCTGGACTCAG CTGGGAGAGCGTGTG GTGTCAGTGTGAAGA AGGGACAAGAGCTGG TGAACATCTACTGCC CAGTTGTCATCTCCA 1080 
Wde I 
QTQGiyATATGbTCA ATACCTATCAGCACT 
ATGCGGGAATGTTCA ATACCTATCAGCACT TGTTGCCAGAGACTG TCCGCCATCTGCCAG ATGTGAAGAAGCAGC TGGCGATGGTAAGGC 1170 
CTGGTCTGAGCATGC TCTCAATCTTCATCT GTCTGAAAGGCACCA AGGAGGACCTGAAGC TTCAGTCCACCAACT ACTATGTTTATTTTG 1260 
ACACAGACATGGACA AAGCGATGGAGCGCT ATGTCTCTATGCCCA AGGAAAAGGCTCCAG AACACATTCCCCTTC TCTTCATTGCCTTCC 1350 
CATCAAGCAAGGATC CAACCTGGGAGGAGC GATTCCCAGACCGAT CCACAATGACTGCGC TGGTACCCATGGCCT TTGAATGGTTCGAGG 1440 
AGTGGCAGGAGGAGC CAAAGGGCAAGCGTG GTGTTGACTATGAGA CCCTCAAAAATGCCT TCGTGGAAGCCTCTA TGTCGGTGATCATGA 1530 
AACTGTTCCCACAGC TGGAGGGCAAGGTGG AGAGTGTGACTGGAG GGTCACCACTGACCA ACCAGTACTATCTGG CTGCACCCCGAGGAG 1620 
CTACCTATGGAGCTG ACCATGACTTGGCTC GGCTGCATCCTCATG CAATGGCTTCCATAA GAGCCCAAACCCCCA TCCCCAACCTCTACC 1730 
TGACAGGCCAAGATA TCTTCACCTGTGGGC TGATGGGGGCCCTGC AGGGGGCCTTGCTGT GCAGCAGTGCCATCC TGAAACGGAACTTGT 1800 
Sap I 
S Z G - R P - S a p X GTTCCGTQTTTTCT TCTTCTACACGC|CTT cfCG|TTGGTGG 
A C T C A G A T C T G C A G G C T C T T G G C T C A A A G G TCAAGGCACAAAAGA A G A A G A T G H T C C G TTCAGAGAAGAGCCA G A G G A A A G G C A C C T C 1 8 9 0 
C C C A A C T T C T C G T G G T G T C C T C C C T C C T A C A G C A A T T C C T T G C A C A T A T A A A C A A A A A C C A T T T T G T T T C T G A T T A G T G T T G T T A A G T C A 1 9 8 0 
A G A G T T C T T T A C C T T G C A T T C T A C T T A A G G C C T A G T G T G A A C T A C A T A G C C T T G A T G C C T C A T G A A G A A T G C T C C C A T G C C T T T C C T A C A 2 0 7 0 
C C C A A C T C C A A G C T A T G G T C A G G C A C C C A G A A C C C C T G G G G T G T T G G C T A C T G G A A T A G G T T G G T T C A G T C C T A C C C T G A A G C T T T T T G T 2 1 6 0 
T C C T C C T C A C T C T C G T G T T G T G A T G C T C T A T A C A T G G A A A A G T G T G G G C T T G G A G T A G C A A C T C T C T C A A A G T G C C A G A C C T A A G A A A A C 2 2 5 0 
C C T C A G G T C T A A G T T T T A T C C T G A T A G A A G TGGGTTAAAGGAACA CACCAAAAGATACCA C T G C C G A T G A A C C A A G C C T A G A C A C G G C A T 2 3 4 0 
T T G T A G T T G C T G G C A C A T A G T C A A A C T G A G T T A C G A G G C T G G G C A G T G C T G G C A C C G G C C T T T A A C C C C A G C A C T CAGAAGGCAGGGGCA 2 4 3 0 
G A C A G A G C T C T G T G A A T C T G A A G C C A G A A C T A G T T T A T G A A G C A A GTCCAGGGCAGCCAG A G C T C T G T T A T A C A G A G A A A C C C T G T C T T G 2 5 2 0 
A A A A A C A A A A C A A G G CAAAACAAAACCTGA G T A T T G T T T T C T A A A A T G C T T G G A G T C A G A A T T C T T T C A G A T T T T G T A G T A T T T G C A T A C 2 6 1 0 
A C A T G A G A T A A C C T G G G G A A T G G G T C C C A G A A C T A A A C C A C A A A T T C A T T T G T T T C A T A T G T A T A G A C C A G G C A C A A C A T C T T A T G T A A T 2 7 0 0 
A C T T T G A A A A A C T G A G C A T T C T G A C C T G T C A C A T G A G T C C A T G C T A T A A T T T A A A A A G C T T G C T T T G A T T T C A G A A T A G G G A T G C T T T A C 2 7 9 0 
C T A T A T G A G T A A A T G AGAAGGTGGATAAAA A T T A A A A A C C T T T C A C T T A T G T T A A A C A A G T G C T A A T T T T A G T C T G T T T A A A T A T A G T A T 2 6 8 0 
T A A T A C A T G T A A T G T T T C A A 2 9 0 0 
Figure 2.4 Primer design for PCR amplification of PPSIG containing Nde I 
and Sap I sites for cloning into pThioHis vector 
A set of primers (highlighted in yellow) designed to amplify a partial PPSIG cDNA of 
792 bp included a forward primer located at 1089 bp of the full length PPSIG cDNA 
containing the Nde I digestion site and a reverse primer located at 1853 bp region 
containing the Sap I site that excluded the stop codon (highlighted in blue). The start 
codon of the full length PPSIG was highlighted in red. 
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water with a total volume of 50 Both digestion mixtures were kept in a 37°C 
water bath overnight. The digested DNA was resolved on 1% or 1.5% agarose gels. 
The DNA band was visualized on a UV Transilluminator (UVP M20), cut out with a 
razor blade and gel-purified using the Qiagen QIAquick gel extraction kit (Hilden, 
Germany). 
2.3.3 Restriction enzyme digestion of PPSIG cDNA 
insert and pTYB vector 
The PPSIG cDNA insert and the expression vector pTYB were 
double-digested with Nde I and Sap I overnight at 37°C. Digestion mixture of 
cDNA insert contained 2 ^g cDNA, 20 U Nde I, 3 U Sap I, and IX NEBuffer 4 in 100 
|Lil of autociaved distilled water. Digestion mixture of pTYB vector contained 5 i^g 
DNA, 60 U Nde I，6 U Sap I, and IX NEBuffer 4 in 100 i^l of autociaved distilled 
water. The digested DNA were resolved on 0.6% or 1.5% agarose gels, cut out with 
a razor blade and gel-purified using QIAquick gel extraction kit. DNA concentration 
was measured by absorbance at 260 run. 
2.3.4 Ligation and transformation 
Ligation was carried out with digested PGR product and expression vector in a 
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3 ： 1 molar ratio at 16°C overnight. For cloning into pThioHis vector, the ligation 
mixture contained 100 ng vector DNA, 52.5 ng insert cDNA, 0.5 U T4 DNA ligase 
and IX ligase buffer in 10 |j,l NF water. For cloning into pTYB vector, the ligation 
mixture contained 100 ng vector DNA, 32 ng insert cDNA, 0.5 U T4 DNA ligase and 
IX ligase buffer in 10 |al NF water. The ligation product was incubated on ice with 
200 competent cells (TOP 10 for pThioHis vector and HBlOl for pTYB vector) 
before applying a 90 s heat shock at 42°C. After standing on ice for a further 2 min, 
800 |j.l LB medium was added to the mixture and the culture was shaken at 250 rpm at 
37°C for 1 h using an orbital shaker (Lab-Line). Cells were pelleted by 
centrifugation at 2,500 rpm for 8 min and 800 jil supernatant was removed. After 
resuspending in the remaining 200 supernatant, the transformed cells were spread 
on an LB agar plate containing 50 |ig/ml ampicillin and allowed to grow at 37°C 
overnight. 
2.3.5 Screening for recombinants by phenol/chloroform 
method 
Clones containing recombinant plasmids were screened by phenol/chloroform 
method to check whether the plasmid had the expected size. A 20 i^l of overnight 
culture of the bacterial colonies were added to 20 of phenol/chloroform and 
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vortexed for 1 min. After centrifugation at 14,000 rpm for 1 min at 4°C, the 
supernatant was loaded on a 0.7% agarose gel. Clones having plasmids of desired 
size were grown in 5 ml LB containing 50 |ag/ml ampicillin and plasmid DNA was 
purified using the Mini-M® plasmid DNA extraction system (Viogene, Sunnyvale, 
CA, USA). 
2.3.6 Confirmation of recombinant plasmid by 
restriction enzyme digestion 
2.3.6.1 Digestion of pThioHis-PPSIG plasmid with Xba I and 
Sac II 
Restriction enzyme digestion was performed to check if the plasmid carried 
PPSIG insert. A 0.5 \ig plasmid DNA was digested with 20 Xba I and 20 U Sac II, 
in 1X NEBuffer 2 and 1X BSA in 20 |il of autoclaved distilled water. After 
overnight incubation in a 37°C water bath, the digestion mixture was resolved on a 
1% agarose gel. 
2.3.6.2 Digestion of pTYB-PPSIG plasmid with Ecol^ V 
Restriction enzyme digestion was performed using 0.5 |Lig plasmid DNA in a 
digestion mixture containing 10 U EcoR V, IX NEBuffer 3, and IX BSA in 20 of 
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autoclaved distilled water at 37°C overnight. The digestion mixture was resolved on 
a 0.7% agarose gel. 
2.3.7 Transformation into expressing E. coli strains 
After confirming the recombinant plasmid by restriction enzyme digestion, 
the plasmid was transformed into a suitable expressing E. coli strain with the same 
transformation procedure described in section 2.3.4. The pThioHis-PPSIG plasmid 
was transformed into BL21 star (DE3) competent cells and the pTYB-PPSIG plasmid 
into ER2566 competent cells for Thio-PPSIG and Intein-PPSIG fusion protein 
expression respectively. 
2.4 Over-expression of PPSIG proteins in E. coli 
Overnight bacterial culture containing the desired DNA plasmid was 
inoculated in 100 volume of fresh LB medium (1% bacto-yeast extract, 0.5% 
bacto-tryptone and 1% NaCl) for 37°C incubation with orbital shaking in a Lab-line 
Environ Shaker until absorbance at 600 nm reached 0.6. Protein induction was 
carried out at 37°C for 4 h in the presence of 1 mM IPTG. Bacterial cells were 
pelleted at 6,000 g for 15 min and resuspended in 1/10 volume of wash buffer (2 mM 
Tris-HCl, pH 7.5, 10 mM EDTA and 1 % Triton X-100). Lysozyme was added to the 
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resuspension to a final concentration of 0.2 mg/ml for a 15-min incubation at 30°C. 
Proteins were released by sonication for 3 x 10 s using the Ultrasonic Processor 
(DAIGGER GE130PB). Insoluble proteins were expressed as inclusion bodies and 
were collected by centrifugation at 10,000 g for 10 min. They were solubilized in 
solubilization buffer (50 mM 3-(cyclohexylamino)-1-propane sulphonic acid (CAPS) 
and 3% N-lauroylsarcosine) and refolded by dialysis first in 20 mM Tris-HCl (pH 8.5) 
with 0.1 mM DTT, then in 20 mM Tris-HCl only. The refolded intein-PPSIG 
proteins were then semi-purified on a preparative SDS-PAGE (see section 2.5) for 
rabbit immunization. For thio-PPSIG, the proteins were loaded on a nickel column 
and eluted with 50 mM of imidazole in column wash buffer (20 mM sodium 
phosphate, 500 mM NaCl, pH 6.0) before it was semi-purified. 
2.5 Semi-purification of PPSIG fusion proteins by 
preparative SDS-PAGE 
About 1 mg of refolded fusion proteins were prepared in sample buffer (25 
mM Tris-HCl, pH 6.8，5% glycerol, 1% sodium dodecyl sulphate, 0.01% 
bromophenol blue and 14.4 mM beta-mercaptoethanol) and boiled for 10 min before 
loading on an 16 cm x 18 cm x 1.5 mm preparative SDS-PAGE gel [separating gel: 
8% or 10 % acrylamide/bis-acrylamide (37.5:1) as indicated in the figures, 0.1 % SDS, 
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0.375 M Tris-HCl, pH 8.8; stacking gel: 4% acrylamide/bis-acrylamide (37.5:1), 0.1 
% SDS, 0.125 M Tris-HCl, pH 6.8]. The gel was assembled in an Amersham SE 
600 standard dual cooled vertical unit (Buckinghamshire, England) and 
electrophoresed at 50 V for 16 h (running buffer: 25 mM Tris, 192 mM glycine, 0.1 % 
SDS). The gel was stained with 1% Coomassie brilliant blue R in water and 
destained with water. Protein band was excised out and homogenized in Phosphate 
Buffered Saline (137 mM sodium chloride, 2.7 mM potassium chloride, 10.1 mM 
dibasic sodium phosphate and 1.7 mM monobasic potassium phosphate) in a 
Teflon-glass homogenizer using a Wheaton overhead stirrer. 
2.6 Rabbit immunization 
The homogenized protein band containing the desired fusion protein antigen 
was mixed with the same volume of Sigma Freund's adjuvant (St. Louis, MO, USA) 
and passed through two syringes until emulsification occurred. Pre-immune blood 
was collected from two 3-month old New Zealand White rabbits from their ear veins. 
Each fusion protein antigen was injected subcutaneously at the neck of the rabbit 
following standard protocols (Kakar et al. 2001; Marikar et al. 2006; Poland et al 
1991). Five boosts were injected at 1 -month intervals and blood was collected 10-14 
days after each boost. Blood collected was allowed to coagulate at room 
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temperature for 1 h, followed by two consecutive centrifugations at 2,500 g for 20 
min at room temperature. The supernatant was stored as serum for Western blotting. 
2.7 Northern blotting analysis 
2.7.1 Probe preparation 
DIG-labelled cDNA probe was produced using the RACE clone (5，1132) 
amplified with a forward primer 5 ‘ -GAGCCCTGGCAGC AACAT-3' and a reverse 
primer 5'-GCCTTGACCTTTGAGCC-3' (Figure 2.5). The PCR reaction contained 
20 ng RACE DNA template, 2 U Taq DNA polymerase (Genesys, UK), 1.5 mM 
MgCb, 1 i^ M forward primer, 1 [iM reverse primer, 0.2 mM PCR DIG labelling mix 
and IX PCR buffer in 50 [x\ autoclaved distilled water. The reaction was performed 
first at 95�C for 7 min, followed by 30 cycles at 95�C for 30 s, 60°C for 1 min and 
72°C for 2 min 15 s using a thermocycler (Applied Biosystem GeneAMP PCR 9700). 
2.7.2 Formaldehyde-agarose gel electrophoresis, 
blotting of RNA and hybridization 
Northern blotting analysis was carried out using samples from mice described 
in section 2.2. PPARa wild-type and knockout mice were sacrificed by cervical 
dislocation and their livers were obtained. About 0.5 g of each liver was 
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S I G - F P GAGCC CTGGCAGCAACAT 
G C G G T C T T C C G A G C C C T G G C A G C A A C U T G G A T C A C T G C T C T G C T G C T G G C C G T G C T G C T G C T G G T G A T C C T C C A C A G G G T C T A C G T G G 9 0 
G C C T T T A C G C T G C A A G T T C C C C G A A C C C C T T C G C C G A G G A T G T C A AGCGACCGCCTGAAC C C C T G G T G A C C G A C A AGGAGGCTAGGAAGA 1 8 0 
A A G T T C T C A A A C A A G C T T T C T C A G T C A G C C GAGTACCAGAGAAGC T G G A T G C A G T G G T G A T C G G C A G C G G C A T T G G G G G A C T G G C C T C A G 2 7 0 
C T G C G G T T C T A G C T A AAGCTGGCAAGAGAG T C C T T G T G C T G G A A C AACATACCAAGGCGG G C G G C T G T T G T C A T A C C T T T G G G G A A A A T G 3 6 0 
G C C T T G A A T T T G A C A C T G G A A T T C A T T A T A TTGGACGAATGCGGG AGGGCAACATTGGCC G T T T T A T C T T G G A C C A G A T C A C T G A A G G G C 4 5 0 
A A C T G G A C T G G G C C C C C A T G G C C T C C C C T T T T G A C T T G A T G A T A C TAGAAGGGCCCAATG GCCGAAAGGAGTTCC C C A T G T A C A G T G G G A 5 4 0 
G G A A A G A A T A C A T C C A G G G C C T T A A G A A G A AGTTCCCCAAGGAAG A A G C T G T C A T T G A C A A G T A C A T G G A G T T G G T T A A G G T G G T G G C C C 6 3 0 
G T G G A G T C T C T C A T G C A G T T C T A C T C A A G T T C C T C C C A T T G C C C T T G A C T C A G C T C C T C A G C A A G T T T G G G C T A C T G A C T C G T T T C T C T C 7 2 0 
C A T T C T G C C G A G C G T C T A C G C A G A G C C T A G C T G A A G T C C T G C A G C A G C T T G G G G C T T C C C G T G A G C T C C A G G C T G T T C T C A G C T A C A T C T 8 1 0 
T C C C C A C T T A C G G A G T A A C T C C C A G C C A C A C C G C C T T T T C C T T G C A T G C T C T G C T G G T T G A C C A C T A C A T A C A A G G G G C A T A T T A C C C T C 9 0 0 
G A G G G G G T T C C A G T G A G A T C G C C T T C C A T A C C A T C C C T T T G A T T C AGCGGGCCGGGGGCG C T G T C C T C A C C A G G G C C A C T G T A C A G A G T G 9 9 0 
T G C T G C T G G A C T C A G C T G G G A G A G C G T G T G G T G T C A G T G T G A A G A AGGGACAAGAGCTGG T G A A C A T C T A C T G C C C A G T T G T C A T C T C C A 1 0 8 0 
A T G C G G G A A T G T T C A A T A C C T A T C A G C A C T T G T T G C C A G A G A C T G T C C G C C A T C T G C C A G ATGTGAAGAAGCAGC T G G C G A T G G T A A G G C 1 1 7 0 
C T G G T C T G A G C A T G C T C T C A A T C T T C A T C T G T C T G A A A G G C A C C A AGGAGGACCTGAAGC T T C A G T C C A C C A A C T A C T A T G T T T A T T T T G 1 2 6 0 
A C A C A G A C A T G G A C A A A G C G A T G G A G C G C T A T G T C T C T A T G C C C A AGGAAAAGGCTCCAG A A C A C A T T C C C C T T C T C T T C A T T G C C T T C C 1 3 5 0 
C A T C A A G C A A G G A T C CAACCTGGGAGGAGC G A T T C C C A G A C C G A T C C A C A A T G A C T G C G C T G G T A C C C A T G G C C T T T G A A T G G T T C G A G G 1 4 4 0 
A G T G G C A G G A G G A G C CAAAGGGCAAGCGTG G T G T T G A C T A T G A G A C C C T C A A A A A T G C C T T C G T G G A A G C C T C T A T G T C G G T G A T C A T G A 1 5 3 0 
A A C T G T T C C C A C A G C TGGAGGGCAAGGTGG AGAGTGTGACTGGAG G G T C A C C A C T G A C C A A C C A G T A C T A T C T G G C T G C A C C C C G A G G A G 1 6 2 0 
CTACCTATGGAGCTG ACCATGACTTGGCTC GGCTGCATCCTCATG CAATGGCTTCCATAA GAGCCCAAACCCCCA TCCCCAACCTCTACC 1730 
TGACAGGCCAAGATA TCTTCACCTGTGGGC TGATGGGGGCCCTGC AGGGGGCCTTGCTGT GCAGCAGTGCCATCC TGAAACGGAACTTGT 1800 
CCGAGTTTCC AGTTCCG SIG-RP 
ACTCAGATCTGCAGG CTCTTGGCTCAAAGG TCAAGGCACAAAAGA AGAAGATGB|TCCG TTCAGAGAAGAGCCA GAGGAAAGGCACCTC 1890 
CCCAACTTCTCGTGG TGTCCTCCCTCCTAC AGCAATTCCTTGCAC ATATAAACAAAAACC ATTTTGTTTCTGATT AGTGTTGTTAAGTCA 1980 
AGAGTTCTTTACCTT GCATTCTACTTAAGG CCTAGTGTGAACTAC ATAGCCTTGATGCCT CATGAAGAATGCTCC CATGCCTTTCCTACA 2 0 7 0 
CCCAACTCCAAGCTA TGGTCAGGCACCCAG AACCCCTGGGGTGTT GGCTACTGGAATAGG TTGGTTCAGTCCTAC CCTGAAGCTTTTTGT 2 1 6 0 
TCCTCCTCACTCTCG TGTTGTGATGCTCTA TACATGGAAAAGTGT GGGCTTGGAGTAGCA ACTCTCTCAAAGTGC CAGACCTAAGAAAAC 2 2 5 0 
C C T C A G G T C T A A G T T T T A T C C T G A T A G A A G TGGGTTAAAGGAACA CACCAAAAGATACCA C T G C C G A T G A A C C A A G C C T A G A C A C G G C A T 2 3 4 0 
TTGTAGTTGCTGGCA CATAGTCAAACTGAG TTACGAGGCTGGGCA GTGCTGGCACCGGCC TTTAACCCCAGCACT CAGAAGGCAGGGGCA 2 4 3 0 
GACAGAGCTCTGTGA ATCTGAAGCCAGAAC TAGTTTATGAAGCAA GTCCAGGGCAGCCAG AGCTCTGTTATACAG AGAAACCCTGTCTTG 2 5 2 0 
AAAAACAAAACAAGG CAAAACAAAACCTGA GTATTGTTTTCTAAA ATGCTTGGAGTCAGA ATTCTTTCAGATTTT GTAGTATTTGCATAC 2 6 1 0 
ACATGAGATAACCTG GGGAATGGGTCCCAG AACTAAACCACAAAT TCATTTGTTTCATAT GTATAGACCAGGCAC AACATCTTATGTAAT 2 7 0 0 
ACTTTGAAAAACTGA GCATTCTGACCTGTC ACATGAGTCCATGCT ATAATTTAAAAAGCT TGCTTTGATTTCAGA ATAGGGATGCTTTAC 2 7 9 0 
CTATATGAGTAAATG AGAAGGTGGATAAAA ATTAAAAACCTTTCA CTTATGTTAAACAAG TGCTAATTTTAGTCT GTTTAAATATAGTAT 2 6 8 0 
TAATACATGTAATGT TTCAA 2900 
Figure 2.5 Primer design for DIG-labelled cDNA probe preparation for 
Northern blotting analysis 
A set of primers (highlighted in yellow) were designed to amplify a DIG-labelled 
cDNA probe of �1800 bp containing the full open reading frame on PPSIG mRNA. 
The start codon and stop codon of PPSIG are highlighted in blue and red respectively. 
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homogenized and its total RNA was extracted by TRIzol® reagent using standard 
protocol provided by the manufacturer. RNA pellet was dissolved in formamide and 
its concentration was determined by its absorbance at 260 nm. A 30 |ag of each 
sample prepared in core mix (5% formaldehyde, 0.6X loading dye in IX MOPS) was 
denatured at 68°C and resolved on a 1 %-fonnaldehyde agarose gel (1% formaldehyde, 
1% agarose in IX MOPS). After electrophoresed at 25 V for 16 h, the gel was 
incubated in lOX SSC (3 M sodium chloride, 0.3 M sodium citrate, pH 7.0) for 45 
min and the sample was transferred to a positively charged N+ nylon membrane (Pall, 
East Hills, NY, USA) by upward capillary force overnight. After washing in 5X 
SSC, the membrane was baked at 80°C for 2 h in an oven (Memmert UM300) in 
order to fix the RNA onto the membrane. The membrane was pre-hybridized in 
DIG-Easy hyb buffer (Roche, Germany) with gentle shaking at 42°C for 2 h. 
Hybridization was carried out overnight with shaking at 42°C in DIG-Easy hyb buffer 
containing the DIG-labelled cDNA probe described in section 2.7.1. The membrane 
was then washed first in low stringency buffer (0.1% SDS in 2X SSC) twice for 5 min 
at room temperature and then in high stringency buffer (0.1%SDS in 0.5X SSC) twice 
for 5 min at 68°C. After blocking the membrane in IX blocking buffer [1% (g/v) 
blocking reagent in 0.1 M maleic acid and 0.15 M sodium chloride, pH 7.5] for 1 h, 
the membrane was incubated in anti-DIG-AP (Roche, Germany) solution (1:10000 
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diluted in IX blocking buffer) for 1 h, before it was washed in washing buffer [0.3% 
(v/v) Tween 20® in 0.1 M maleic acid and 0.15 M sodium chloride, pH 7.5]. The 
signal was developed in nitroblue tetrazolium chloride (NBT) and 
5-bromo-4-chloro-3-indolyl-phosphate-4-toluidine salt (BCIP) solution (Roche, 
Mannheim, Germany) and captured with a scanner (Epson GT-9500). 
2.8 Subcellular fractionation 
Subcellular fractionation was carried out with modifications from several 
protocols (Bektas et al 2005; Dressman et al 2000; Le Stunffe/ al 2002; 
Okado-Matsumoto and Fridovich 2001). About 1 g of liver was minced and added 
to 30 ml with homogenizing buffer (0.1 M sodium phosphate, pH 7.4, 0.125 M 
potassium chloride, 1 mM ethylenediaminetetra acetic acid, 1 mM 
phenylmethylsulfonyl fluoride (PMSF), 1 mM dithiothreitol and 0.25 M sucrose) in a 
Teflon-glass homogenizer. The livers were homogenized using the Wheaton 
overhead stirrer with a speed no more than 2. The centrifugation procedure was 
summarized in Figure 2.6. The homogenate was centrifuged in Himac CR 21 
centrifuge using rotor 23 at 1,000 g for 10 min at 4 � C to obtain the pellet PI (nucleus). 
The resultant supernatant was centrifuged at 3,000 g for 10 min at 4°C to obtain the 
second pellet P2 (heavy mitochondria). The third pellet P3 (light mitochondria) was 
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Liver homogenate 
1,000 g, 10 min 
P1 Pellet Supernatant 
(Nucleus) 
3,000 g, 10 min 
P2 Pellet Supernatant 
(Heavy mitochondria) 
12,000 g, 20 min 
P3 Pellet Supernatant 
(Light mitochondria) 
100,000 g, 1 h 
P4 Pellet Supernatant 
(Microsomes) (Cytosol) 
Figure 2.6 Flowchart for subcellular fractionation procedure 
Liver homogenate was centrifuged at 1,000 g to pellet nucleus (PI), 3,000 g to pellet 
heavy mitochondria (P2) and 12,000 g to pellet light mitochondria (P3). 
Microsomes (P4) were pellet by centrifugation at 100,000 g and the supernatant was 
referred to as cytosol. 
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obtained by centrifugation at 12,000 g for 20 min at 4°C. Lastly, a P4 pellet 
(microsomes) was obtained by centrifugation at 100,000 g for 1 h at 4°C in a 
Beckman Optima'^^ XL-1OOK Ultracentrifuge using rotor 70Ti. Each pellet was 
washed twice by repeated resuspension and centrifugation. The pellet was finally 
homogenized in radio-immunoprecipitation assay (RIPA) buffer (50 mM Tris-HCl, 
pH 7.5, 150 mM sodium chloride, 1% ethylphenyl-polyethylene glycol (NP-40), 0.5% 
sodium deoxycholate, 1 mM PMSF and Roche complete protease inhibitor cocktail). 
Protein concentration was measured by BCA™ protein assay kit (Pierce, Rockford, IL, 
USA) according to the manufacturer's instructions. 
2.9 Western blotting of liver microsomes 
Liver microsomes were prepared in sample buffer and boiled for 10 min 
before loading on a 16 cm x 18 cm x 0.75 mm SDS-PAGE gel. The gel was 
electrophoresed at 50 V for 16 h using an Amersham SE 600 standard dual cooled 
vertical unit, and proteins were blotted onto a 0.45 |am Pall BioTrace™ PVDF 
Transfer Membrane (East Hills, NY, USA) at 70 V for 1 h using an Amersham TE 62 
transfer cooled unit (Buckinghamshire, England) (transfer buffer: 25 mM Tris, 192 
mM glycine, 20% methanol). The blocked membrane was incubated with shaking 
on an orbital shaker platform (Scienceware, Spindrive®) with primary antibody 
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solutions overnight at 4°C, then with secondary antibody solution (Zymed alkaline 
phosphatase (AP)-goat anti-rabbit IgG, 1:2000; Zymed AP-goat anti-mouse IgG, 
1:2000) for 2 h. After washing, membrane was developed colourimetrically using 
NBT and BCIP as substrate (Roche, Mannheim, Germany) and captured with a 
scanner (Epson GT-9500). 
2.10 Immunoprecipitation 
Immunoprecipitation was carried out with modifications according to several 
protocols (Crockett et al 2004; Kakar et al 2001; Wuer al 2003). A 1:500 dilution 
of pre-immune serum from the rabbit injected with Thio-PPSIG was added to 500 
microsomes in 1 ml RIPA buffer for 1 h incubation with shaking at 4°C, followed by 
addition of 50 |j,1 protein A-agarose (Roche, Germany) for a further 3 h incubation. 
The pre-immune serum was removed together with protein A-agarose by 
centriftigation at 12,000 g for 20 s. Then a 1:100 dilution of anti-PPSIG antiserum 
was added to the microsomes for 1 h incubation, followed by addition of 50 protein 
A-agarose for incubation overnight at 4°C. The agarose pellet was collected by 
centrifugation at 12,000 g for 20 s and washed according to manufacturer's 
instruction (Roche, Germany). The final pellet was resuspended in 50 )j.l of sample 
buffer and boiled for 10 min. After centrifugation at 12,000 g for 20 s, the 
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supernatant was resolved on an 8-18% gradient SDS-PAGE gel for Western blotting 
analysis using anti-PPSIG antiserum. 
2.11 Mass spectrometry 
2.11.1 Trypsin digestion and peptide extraction 
Digestion and extraction peptides followed a general procedure modified from 
several protocols (Crockett et al 2004; Goumon et al 2006; Suzuki et al 2006). 
Recombinant or immunoprecipitated native PPSIG was resolved on SDS-PAGE gels 
and the protein band was excised into 5-10 discs having a diameter of 1 mm with a 
blunt-end needle. The gel discs were washed with 500 [i\ of 25 mM ammonium 
I 
bicarbonate (NH4HCO3) for 1 h with vortex. They were then dehydrated by three 
consecutives washes each with 100 of 50% acetonitrile / 25 mM NH4HCO3 for 10 
min, followed by a final wash of 100 i^l 100% acetonitrile for 10 min. The gel was 
flushed to complete dryness using a speed vacuum (Savant SCllOA Speed Vac® Plus). 
Proteins in the gel discs were reduced by 30 of 10 mM DTT / 25 mM NH4HCO3 at 
60°C for 30 min. After discarding the DTT solution, 30 of 55 mM iodoacetamide 
/ 25 mM NH4HCO3 was added to the gel discs to alkylate the proteins for 30 min in 
dark. The gel discs were washed and dehydrated to complete dryness as described 
previously, and rehydrated with 20 i^l sequencing grade modified trypsin (Promega, 
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Madison, WI, USA) solution (20 ng/|al trypsin / 25 mM NH4HCO3) for 30 min on ice. 
Another 10 of 25 mM NH4HCO3 was added to cover the gel pieces before 
incubating the gel at 37°C overnight. Digested peptides were extracted with 20 |j,l of 
25 mM NH4HCO3, 20 |il of 50% acetonitrile / 5% trifluoroacetic acid (TFA) for 3 
times and 20 \x\ of 100% acetonitrile consecutively in a sonicating water bath. The 
extracted peptides were flushed to dryness using a speed vacuum, resuspended in 
0.10/0 TFA and purified by passing through ZipTipcig with a column bed of 0.6 |j,l 
(Millipore, Bedford, MA, USA) following manufacturer's protocol. Finally, 
peptides were eluted in 3 [i\ of 50% acetonitrile / 0.1% TFA. 
2.11.2 Matrix-assisted laser desorption/ionization 
time-of-flight (MALDI-TOF) mass spectrometry 
After addition of equal amount of matrix (a-cyano-4-hydroxycinnamic acid), 
0.5 \x\ of sample was applied on a MALDI plate for mass spectrometry analysis on the 
Applied Biosystems 4700 Proteomics Analyzer. Peptide mass fingerprinting (PMF) 
spectrum of each peptide spot was generated automatically by plotting the relative 
intensity of positively charged ions against mass-to-charge (m/z) ratio of the ions in 
the range of 500-5000. High intensity peptide peaks were sequenced by MS/MS by 
generation of fragment ion spectra with an MS fragment tolerance of 0.5 Da. Data 
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from PMF were processed by the Mascot software using the GPS Explorer™ 
Workstation. After removing peaks resulting from trypsin autolysis, the peptide 
peaks were submitted for searching with in the NCBI non-redundant database with no 
missed cleavage allowed and precursor mass tolerance of 100 ppm. 
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Chapter 3 Results 
3.1 Cloning of PPSIG into pThioHis and pTYB vectors 
3.1.1 Cloning of PPSIG into pThioHis vector 
A � 8 0 0 bp partial length of PPSIG cDNA insert containing Sac II and Xba I 
digestion sites was amplified (Figure 3.1). Ligation of Sac II and Xba I digested 
PPSIG insert with a � 4 . 4 kb Sac II and Xba I digested pThioHis C vector (Figure 3.2) 
produced a pThioHis-PPSIG construct of -5.2 kb. Screening of recombinant clones 
by phenol/chloroform method identified 13 clones containing plasmid having the 
same size as pThioHis-PPSIG construct (Figure 3.3A). To confirm the identity of 
the recombinants, 4 clones (3，8, 9 and 12) were selected for DNA plasmid extraction 
followed by restriction enzyme digestion. Double digestion with Sac II and Xba I 
yielded 2 bands of-4.4 kb and � 0 . 8 kb (Figure 3.3B). After DNA sequencing, clone 
9 was found to be 99% identical to the 5'II32 RACE clone generated from the FDD 
fragment with a mutation from leucine to proline (Figure 3.4). Its DNA plasmid was 
then transformed into BL21 star (DE3) competent cells for protein expression. 
3.1.2 Cloning of PPSIG into pTYB vector 
The same partial length of PPSIG cDNA insert of � 8 0 0 kb containing Nde I 
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A Xba I / Sac II digested 
PPSIG PGR fragment 
bp M Before excision M After excision 
oWMMBKMaMMMMi OBBaHMBCaMHBBaMMMta 
l ^ l ^ ^ i m ^ _ j l i i i i i l l l l l g g i l 
800 ^ K S ^ ^ ^ ^ S l S ^ PPSIG cDNA 
二 .0.8 Kb 
B Gel purified cDNA 





Figure 3.1 Preparation of Xba I and Sac II digested partial PPSIG cDNA 
fragment for cloning into pThioHis vector 
(A) Electrophoresis of PGR amplified ?in&Xba I and Sac II digested PPSIG cDNA 
fragment on a 1.5 % agarose gel for gel excision and purification. (B) Gel purified 
PPSIG cDNA insert. M, 100 bp DNA ladder. 
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A Xba I and Sac II digested 
pThioHis vector 
bp M Before excision M After excision 
5 0 9 0 - m j M ^ l mtm 1 
4 0 7 2 V S H B ^ I H ^ P r ^ pThioHis 
3054 A g H B i y M ^ ^ ^ K i vector 
• • 
^ ^ Gel purified vector 
bp M Gel purified 
5090 J pThioHis vector 
-4.4 kb 
• 
Figure 3.2 Preparation of Xba I and Sac II digested pThioHis vector 
(A) Electrophoresis of Xba I and Sac II digested pThioHis vector on a 1% agarose gel 





kb S 1 2 4 5 6 7 ( 8 ) ( 9 ) l 0 11 @ 13 
7 g B = D N A 
5 pThioHis-PPSiG 
4 -5.2 kb 
Bacterial 
Xba I and Sac II digestion 
Vector 3 8 9 12 
bp M U D U D U P U D U D 
I Uncut 
船 I n a t i i J l f T l p M f " " ^ " ^ - -4.4 kb 
2036 (pThioHis vector) 
507 (PPSIG 
Figure 3.3 Screening for recombinants by phenol/chloroform method and 
restriction enzyme digestion 
(A) Screening for 13 recombinants using phenol/chloroform method. Four clones 
(in circle) containing a � 5 . 2 kb pThioHis-PPSIG construct were selected for DNA 
plasmid extraction. (B) Restriction enzyme digestion of the extracted plasmid DNA 
with Xba I and Sac II. U, uncut plasmid DNA. D, Xba I and Sac II digested plasmid 
DNA. S，supercoiled DNA ladder. M, 1 kb DNA ladder. 
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T R X - F TGCGGGAATGTICT^TACCTATCAGCACTTGTTGCCAGAGACCGTCCGCCATCTGCCAGA 1 0 1 
S I G 5 ‘ I I 3 2 ATGTTCAATACCTATCAGCACTTGTTGCCAGAGACCGTCCGCCATCTGCCAGA 5 3 
T R X - F TGTGAAGAAGCAGCTGGCGATGGTAAGGCCTGGTCTGAGCATGCTCTCAATCTTCATCTG 1 6 1 
S I G 5 ‘ I I 3 2 TGTGAAGAAGCAGCTGGCGATGGTAAGGCCTGGTCTGAGCATGCTCTCAATCTTCATCTG 1 1 3 
T R X - F TCTGAAAGGCACCAAGGAGGACCTGAAGCTTCAGTCCACCAACTACTATGTTTATTTTGA 2 2 1 
S I G 5 ‘ I I 3 2 TCTGAAAGGCACCAAGGAGGACCTGAAGCTTCAGTCCACCAACTACTATGTTTATTTTGA 1 7 3 
T R X - F CACAGACGTGGACAAAGCGATGGAGCGCTATGTCTCTATGCCCAAGGTIAAAGGCTCCAGA 2 8 1 
S I G 5 , 1 1 3 2 CACAGACGTGGACAAAGCGATGGAGCGCTATGTCTCTATGCCCAAGGAAAAGGCTCCAGA 2 3 3 
TRX-R ACACAT---CCTTNTCT-CATG--CTTCCCATCA-GCA-GGATCCA-CCTGGGAGGAGNG 1 3 0 
T R X - F ACACATTCCCCTTCTCTTCATTGCCTTCCCATO^AGCAAGGATCCAACCTGGGAGGAGCG 3 4 1 
S I G 5 ‘ I I 3 2 ACACATTCCCCTTCTCTTCATTGCCTTCCCATCAAGCAAGGATCCAACCTGGGAGGAGCG 2 9 3 
TRX - R ATTCCCAGACCGATCCACAATGACTGCGCTGGTACCCATGGCNTTTGNATGGTTCGAGGA 1 9 0 
T R X - F ATTCCCAGACCGATCCACAATGACTGCGCTGGTACCCATGGCCTTTGAATGGTTCGAGGA 4 0 1 
S I G 5 ' 1 1 3 2 ATTCCCAGACCGATCCACIAATGACTGCGCTGGTACCCATGGCCTTTGAATGGTTCGAGGA 3 5 3 
S E Q 1 5 4 7 GTGGTGTNNACTATGAGACCNN-AAAAATGCCTT 3 3 
TRX-R GTGGCAGGAGGAGCCAAAGGGCAAGCGTGGTGTTGACTATGAGACCCICAAANATGCNNT 2 5 0 
T R X - F GTGGCAGGAGGAGCCAAAGGGCAAGCGTGGTGTTGACTATGAGACCCICAAAAATGCCTT 4 6 1 
S I G 5 ‘ I I 3 2 GTGGCAGGAGGAGCCAAAGGGCAAGCGTGGTGTTGACTATGAGACCCTCAAAAATGCCTT 4 1 3 
S E Q 1 5 4 7 CGTGGAAGC-TCTATGTCGGTGATCATGGAACTGTTCCCACGGCTGGAGGGCAAGGTGGA 9 2 
TRX - R CGTGGAAGCCTCTATGTCGGTGATCATGGAACTGTTCCCACGGCTGGAGGGCAAGGTGGA 3 1 0 
TRX- F CGTGGAAGCCTCTATGTCGGTGATCATGGAACTGTCCCCACNGCTGGAGGGCNAGGTGGA 5 2 1 
S I G 5 , 1 1 3 2 CGTGGAAGCCTCTATGTCGGTGATCATGGAACTGTTCCCACGGCTGGAGGGCAAGGTGGA 4 7 3 
S E Q 1 5 4 7 GAGTGTGACTGGAGGGTCACCACTGACCACCCAGTACTATCTGGCTGCACCCCGAGGAGC 1 5 2 
TRX-R GAGTGTGACTGGAGGGTCACCACTGACCAACCAGTACTATCTGGCTGCACCCCGAGGAGC 3 7 0 
T R X - F GAGTGTGACTGGAGGGTCACCACTGACCAACCAGTACTATCTGGCTGCACCCCGAGGAGC 5 8 1 
S I G 5 . 1 1 3 2 GAGTGTGACTGGAGGGTCACCACTGACCAACCAGTACTATCTGGCTGCACCCCGAGGAGC 5 3 3 
S E Q 1 5 4 7 TACCTATGGAGCTGACCATGACTTGGCTCGGCTGCATCCTCATGCAATGGCTTCCATAAG 2 1 2 
TRX - R TACCTATGGAGCTGACCATGACTTGGCTCGGCTGCATCCTCATGCAATGGCTTCCATAAG 4 3 0 
T R X - F TACCTATGGAGCTGACCATGACTNGGCTCGGCTGCATCCTCATGCCNNGNCNTCCATAAG 6 4 1 
S I G 5 ‘ I I 3 2 TACCTATGGAGCTGACCATGACTTGGCTCGGCTGCATCCTCATGCAATGGCTTCCATAAG 5 9 3 
S E Q 1 5 4 7 AGCCCAAACCCCCATCCCCAACCTCTACCTGACAGGCCAAGATATCTTCACCTGTGGGCT 2 7 2 
TRX - R AGCCCAAACCCCCATCCCCAACCTCTACCTGACAGGCCAAGATATCTTCACCTGTGGGCT 4 9 0 
T R X - F AGCCNNA- CCCCCATCCCCAAC - TCTACCTGACGG - - CNAGAT - TCTN - ACCTGTNG - CT 6 9 4 
S I G 5 1 1 1 3 2 AGCCCAAACCCCCATCCCCAACCTCTACCTGACAGGCCAAGATATCTTCACCTGTGGGCT 6 5 3 
S E Q 1 5 4 7 GATGGGGGCCCTGCAGGGGGCCTTGCTGTGCAGCAGTGCCATC C T G A A - - - A C 3 2 2 
TRX-R GATGGGGGCCCTGCAGGGGGCCTTGCTGTGCAGCAGTGCCATC C T G A A - - - A C 5 4 0 
TRX - F GATGGNN——CTGCCGGG——CCTGCTGT-CAGC-GTGC-ATCTGACCGACTGTATNNAT 7 4 5 
S I G 5 . 1 1 3 2 GATGGGGGCCCTGCAGGGGGCCTTGCTGTGCAGCAGTGCCATC C T G A A - - - A C 7 0 3 
S E Q 1 5 4 7 GGAACTTGTACTCAGATCTGCAGG-CTCTTGG-CTCAAAGGTCAAGGCACAAAAGAAGAA 3 8 0 
TRX - R GGAACTTGTACTCAGATCTGCANGNCTCTTGGNCTCAAAGGTCAAGGCACAAAAGAAGAA 6 0 0 
T R X - F GCAGCTTTT 7 5 4 
S I G 5 ‘ I I 3 2 GGAACTTGTACTCAGATCTGCAGG-CTCTTGG-CTCAAAGGTCAAGGCACAAAAGAAGAA 7 6 1 
S E Q 1 5 4 7 GATGTAGTCCGTTCAGAGAAG-CTCTAGAGTCGACCTGCAGTAATCGTACAGGGTAGTAC 4 3 9 
TRX - R GATGTAGTCCGTTCAGAGAAGNCTCTAGAGTCGACCNGCAGTAATNGTACAGGGTAGTAC 6 6 0 
S I G 5 ‘ I I 3 2 GATGTAG 7 6 8 
Figure 3.4 DNA sequencing of pThioHis-PPSIG plasmid 
The DNA sequence of clone 9 was 99% identical to the RACE clone sequence (SIG 
5，1132), with a mismatch at the 5' position (highlighted in purple) and a mutation from 
T (401) to C (highlighted in green) that changes the resulting amino acid from leucine 
to proline. It was used for expression of Thio-PPSIG fusion protein. 
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and Sap I digestion sites was amplified (Figure 3.5). The � 7 . 5 kb Nde I and Sap I 
digested pTYBl vector (Figure 3.6) was ligated with Nde I and Sap I digested PPSIG 
insert, giving a pTYB-PPSIG construct of � 8 . 3 kb. After screening of recombinant 
clones (Figure 3.7A), 2 clones (5 and 9) were selected for DNA plasmid extraction 
and the identity of the plasmid was confirmed to be pTYB-PPSIG by restriction 
enzyme digestion with EcoR V, which yielded 2 bands at � 5 . 5 kb and � 2 . 8 kb (Figure 
3.7B). Clone 5 was selected for DNA sequencing, which gave 100% identity with 
the 5'1132 RACE clone (Figure 3.8). It was transformed into ER 2566 competent 
cells for protein expression. 
3.2 Protein expression of Thio-PPSIG and Intein-PPSIG 
Thio-PPSIG was expressed as a � 4 3 kDa fusion protein, which was in 
agreement with that of a -28 kDa PPSIG protein fused with a � 1 5 kDa His-Patch 
thioredoxin tag at the N-terminal (Figure 3.9). The thioredoxin tag was expressed as 
a - 1 5 kDa protein in E. coli transformed with pThioHis vector. Both could be 
lighted up by anti-thio antibody in Western blottings. Similarly, Intein-PPSIG was 
expressed as a � 8 7 kDa protein, which corresponded to a � 2 8 kDa PPSIG fused with 
a - 5 9 kDa CBD-intein tag at the C-terminal (Figure 3.10). Both intein-PPSIG and 
the intein tag were lighted up by anti-CBD antiserum, confirming the presence of 
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A Sap I and Nde I digested 
PPSIG PCR fragment 
bp M Before excision M After excision 
1636 
PPSIG cONA 
5 0 7 - ^ ^ ^ H H H ~0.8kb 
396 
B Gel purified cDNA 
bp M Gel purified 
Q S ^ I H j j ^ H 
PPSIG cDNA 
^ ^ ^ ^ ^ ^ m n n ^ kb 
Figure 3.5 Preparation of Sap I and Nde I digested partial PPSIG cDNA 
fragment for cloning into pTYBl vector 
(A) Electrophoresis of PCR amplified Sap I and Nde I digested PPSIG cDNA 
fragment on a 1.5 % agarose gel for gel excision and purification. (B) Gel purified 
PPSIG cDNA insert. M, 1 kb DNA ladder. 
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A Sap 丨 and Nde • digested 
pTYB vector 
bp M Before excision M After excision 
8 1 4 4 w m ^ 1 I F W ^ • 
e i O s I ^ B ^ ^ ^ M ^ pTYB vector 
^ ^ Gel purified vector 




Figure 3.6 Preparation of Sap I and Nde I digested pTYBl vector 
(A) Electrophoresis of Sap I and Nde I digested pTYB vector on a 0.6% agarose gel 
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Figure 3.7 Screening for recombinants by phenol/chloroform method and 
restriction enzyme digestion 
(A) Screening for 10 recombinant clones using phenol/chloroform method. Two 
clones (in circle) containing a � 8 . 3 kb pTYB-PPSIG construct were chosen for DNA 
plasmid extraction. (B) Restriction enzyme digestion of the extracted plasmid DNA 
with EcoR V. S，supercoiled DNA ladder. M, 1 kb DNA ladder. 
44 
RP 7 9 3 9 TGTTTAACTTTAAGAAGGAGATATACATATGTTCAATACCTATCAGCACTTGTTGCCAGA 1 3 6 1 
S E Q 1 9 4 8 R - GTTTAACTTTA - GAAGGAGATATACATATGTTCAATACCTATCAGCACTTGTTGCCAGA 7 7 2 
S I G 5 ‘ I I 3 2 ATGTTCAATACCTATCAGCACTTGTTGCCAGA 3 2 
T7 -GTTTAACTTTAAGAAGGAGATATACATATGTTCAATACCTATCAGCACTTGTTGCCAGA 7 6 
RP7 9 3 9 GNCCGTCCGCCATCTGCCAGATGTGAAGAAGCAGCTGGCGATGGTAAGGCCTGGTCTGAG 1 4 2 1 
S E Q 1 9 4 8 R GACCGTCCGCCATCTGCCAGATGTGAAGAAGCAGCTGGCGATGGTAAGGCCTGGTCTGAG 8 3 2 
S I G 5 I 1 1 3 2 GACCGTCCGCCATCTGCCAGATGTGAAGAAGCAGCTGGCGATGGTAAGGCCTGGTCTGAG 9 2 
T7 GACCGTCCGCCATCTGCCAGATGTGAAGAAGCAGCTGGCGATGGTAAGGCCTGGTCTGAG 1 3 6 
R P 7 9 3 9 CATGCTCTCAATCTTACATGCTGTCTGAAAGGCACCAAGGAGGACCTGAAGCTTCAGTCC 1 4 8 1 
S E Q 1 9 4 8 R CATGCTCTCAATCTT-CAT-CTGTCTGAAAGGCACCAAGGAGGACCTGAAGCTTCAGTCC 8 9 0 
S I G 5 ‘ I I 3 2 CATGCTCTCAATCTT-CAT-CTGTCTGAAAGGCACCAAGGAGGACCTGAAGCTTCAGTCC 1 5 0 
T7 CATGCTCTCAATCTT-CAT-CTGTCTGAAAGGCACCAAGGAGGACCTGAAGCTTCAGTCC 1 9 4 
S E Q 1 2 7 2 TGCTCTCA-TCTT-CAT-CTGTCTGAAAGGCACCAAGGAGGACCTGAAGCTTCAGTCC 5 5 
R P 7 9 3 9 ACCAACTACTATGTTTATTT-GACAC 1 5 0 6 
S E Q 1 9 4 8 R ACCAACTACTATGTTTATTTTGACACAGACGTGGACAAAGCGATGGAGCGCTATGTCTCT 9 5 0 
S I G 51 1 1 3 2 ACCAACTACTATGTTTATTTTGACACAGACGTGGACAAAGCGATGGAGCGCTATGTCTCT 2 1 0 
T7 ACCAACTACTATGTTTATTTTGACACAGACGTGGACAAAGCGATGGAGCGCTATGTCTCT 2 5 4 
S E Q 1 2 7 2 ACCAACTACTATGTTTATTTTGACACAGACGTGGACAAAGCGATGGAGCGCTATGTCTCT 1 1 5 
S E Q 1 9 4 8 R ATGCCCAAGGAAAAGGCTCCAGAACACATTCCCCTTCTCTTCATTGCCTTCCCATCAAGC 1 0 1 0 
S I G 5 ' I I 3 2 ATGCCCAAGGAAAAGGCTCCAGAACACATTCCCCTTCTCTTCATTGCCTTCCCATCAAGC 2 7 0 
T7 ATGCCCAAGGAAAAGGCTCCAGAACACATTCCCCTTCTCTTCATTGCCTTCCCATCAAGC 3 1 4 
S E Q 1 2 7 2 ATGCCCAAGGAAAAGGCTCCAGAACACATTCCCCTTCTCTTCATTGCCTTCCCATCAAGC 1 7 5 
S E Q 1 9 4 8 R AAGGATCCAACCTGGGAGGAGCGATTCCCAGACCGATCCACAATGACTGCGCTGGTACCC 1 0 7 0 
S I G 5 ‘ I I 3 2 AAGGATCCAACCTGGGAGGAGCGATTCCCAGACCGATCCACAATGACTGCGCTGGTACCC 3 3 0 
T7 AAGGATCCAACCTGGGAGGAGCGATTCCCAGACCGATCCACAATGACTGCGCTGGTACCC 3 7 4 
S E Q 1 2 7 2 AAGGATCCAACCTGGGAGGAGCGATTCCCAGACCGATCCACAATGACTGCGCTGGTACCC 2 3 5 
S E Q 1 5 4 7 CAAGGGCA-GCGTGGTGTTGAC 2 1 
S E Q 1 9 4 8 R ATGGCCTTTGAATGGTTCGAGGAGTGGCAGGAGGAGCCAAAGGGCAAGCGTGGTGTTGAC 1 1 3 0 
S I G 51 1 1 3 2 ATGGCCTTTGAATGGTTCGAGGAGTGGCAGGAGGAGCCAAAGGGCAAGCGTGGTGTTGAC 3 9 0 
T7 ATGGCCTTTGAATGGTTCGAGGAGTGGCAGGAGGAGCCAAAGGGCAAGCGTGGTGTTGAC 4 3 4 
S E Q 1 2 7 2 ATGGCCTTTGAATGGTTCGAGGAGTGGCAGGAGGAGCCAAAGGGCAAGCGTGGTGTTGAC 2 9 5 
S E Q 1 5 4 7 TATGAGACCCTCAAAAATGCCTTCGTGGAAGCCTCTATGTCGGTGATCATGGAACTGTTC 8 1 
S E Q 1 9 4 8 R TATGAGACCCTCAAAAATGCCTTCGTGGAAGCCTCTATGTCGGTGATCATGGAACTGTTC 1 1 9 0 
S I G 5 ' I I 3 2 TATGAGACCCTCAAAAATGCCTTCGTGGAAGCCTCTATGTCGGTGATCATGGAACTGTTC 4 5 0 
T7 TATGAGACCCTCAAAAATGCCTTCGTGGAAGCCTCTATGTCGGTGATCATGGAACTGTTC 4 9 4 
S E Q 1 2 7 2 TATGAGACCCTCAT^AAATGCCTTCGTGGAAGCCTCTATGTCGGTGATCATGGAACTGTTC 3 5 5 
S E Q 1 5 4 7 CCACGGCTGGAGGGCAAGGTGGAGAGTGTGACTGGAGGGTCACCACTGACCAACCAGTAC 1 4 1 
S E Q l 9 4 8 R CCACGGCTGGAGGGCAAGGTGGAGAGTGTGACTGGAGGGTCACCACTGACCAACCAGTAC 1 2 5 0 
S I G 5 ‘ I I 3 2 CCACGGCTGGAGGGCAAGGTGGAGAGTGTGACTGGAGGGTCACCACTGACCAACCAGTAC 5 1 0 
T7 CCACGGCTGGAGGGCAAGGTGGAGAGTGTGACTGGAGGGTCACCACTGACCAACCAGTAC 5 5 4 
S E Q 1 2 7 2 CCACGGCTGGAGGGCAAGGTGGAGAGTGTGACTGGAGGGTCACCACTGACCAACCAGTAC 4 1 5 
S E Q 1 5 4 7 TATCTGGCTGCACCCCGAGGAGCTACCTATGGAGCTGACCATGACTTGGCTCGGCTGCAT 2 0 1 
S E Q 1 9 4 8 R TATCTGGCTGCACCCCGAGGAGCTACCTATGGAGCTGACCATGACTTGGCTCGGCTGCAT 1 3 1 0 
S I G 5 ' I I 3 2 TATCTGGCTGCACCCCGAGGAGCTACCTATGGAGCTGACCATGACTTGGCTCGGCTGCAT 5 7 0 
T7 TATCTGGCTGCACCCCGAGGAGCTACCTATGGAGCTGACCATGACTTGGCTCGGCTGCAT 6 1 4 
S E Q 1 2 7 2 TATCTGGCTGCACCCCGAGGAGCTACCTATGGAGCTGACCATGACTTGGCTCGGCTGCAT 4 7 5 
S E Q 1 5 4 7 CCTCATGCAATGGCTTCCATAAGAGCCCAAACCCCCATCCCCAACCTCTACCTGACAGGC 2 6 1 
S E Q 1 9 4 8 R CCTCATGCAATGGCTTCCATAAGAGCCCAAACCCCCATCCCCAACCTCTACCTGACAGGC 1 3 7 0 
S I G 5 ‘ I I 3 2 CCTCATGCAATGGCTTCCATAAGAGCCCAAACCCCCATCCCCAACCTCTACCTGACAGGC 6 3 0 
T7 CCTCATGCAATGGCTTCCATAAGAGCCCAAANCCCCATCCCCAACCTCTACCTGACAGGC 6 7 4 
S E Q 1 2 7 2 CCTCATGCAATGGCTTCCATAAGAGCCCAAACCCCCATCCCCANCCTCTACCTGACAGGC 5 3 5 
S E Q 1 5 4 7 CAAGATATCTTCACCTGTGGGCTGATGGGGGCCCTGCAGGGGGCCTTGCTGTGCAGCAGT 3 2 1 
S E Q 1 9 4 8 R CAAGATATCTTCACCTGTGGGCTGATGGGGGCCGTGCAGGGGGCCTTGCTGTGCAGCAGT 1 4 3 0 
S I G 5 _ I I 3 2 CAAGATATCTTCACCTGTGGGCTGATGGGGGCCCTGCAGGGGGCCTTGCTGTGCAGCAGT 6 9 0 
T7 AAAGATATCTTCACCTGTGGGCTGATGGGGGCCCTGCAGGGGGCCTTGCTGTGCAGCAGT 7 3 4 
S E Q l 2 7 2 CAAGATATCTTCACCTGTGGGCTGATGGGGGCCCTGCAGGGGGCCTTGCTGTGCAGCAGT 5 9 5 
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S E Q 1 5 4 7 GCCATCCTGAAACGGAACTTGTACTCAGATCTGCAGGCTCTTGGCTCAAAGGTCAAGGCA 3 8 1 
S E Q 1 9 4 8 R GCCATCNNGAA 1 4 4 1 
S I G 5 ' 1 1 3 2 GCCATCCTGAAACGGAACTTGTACTCAGATCTGCAGGCTCTTGGCTCAAAGGTCAAGGCA 7 5 0 
T7 GCCATCCTGAAACGGAACTTGTACTCAAATCTGCAGGCTCTTGGCTCAANG-TCAAGGCA 7 9 3 
S E Q 1 2 7 2 GCCATCCTGAAACGGAACTTGTACTCAGATCTGCAGGCTCTTGGCTCAAAGGTCAAGGCA 6 5 5 
S E Q 1 5 4 7 CAAAAGAAGAAGATGT-GCTTTGCCAAGGGTACCAATGTTTTAATGGCGGATGGGTCTAT 4 4 0 
S I G 5 ' 1 1 3 2 CAAAAGAAGAAGATGTAG 7 6 8 
T7 CAAAA-AAAAAGATGT-GCTTTGCCAAGGGTACCAATGTTTTAATGGCGGATGGGTCTAT 8 5 1 
S E Q 1 2 7 2 CAAAAGAANAAGATGT-GCTTTGCCAAGGGTACCAATGTTTTAATGGCGGATGGGTCTAT 7 1 4 
Figure 3.8 DNA sequencing of pTYB-PPSIG plasmid 
The DNA sequence of clone 5 was 100% identical to the RACE clone sequence (SIG 
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Figure 3.9 Expression and refolding of Thio-PPSIG 
Thio-PPSIG was expressed in BL21 star (DE3) cells as a -43 kDa fusion protein as 
shown in the SDS-PAGE and was absent in cells transformed only with pThioHis 
vector, in which a~15 kDa thioredoxin was expressed. After sonication of bacterial 
culture, the whole lysate was separated by centrifugation into soluble proteins and 
inclusion bodies that contains Thio-PPSIG, which was further refolded and eluted 
with imidazole on a nickel column. Western blotting analysis showed that both 
Thio-PPSIG and thioredoxin were lighted up by anti-thio monoclonal antibody 
(1:5000) in all fractions mentioned above. M, unstained protein standards. 
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Intein-PPSIG 
SDS-PAGE Western blotting 
Anti-CBD antibody 
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Figure 3.10 Expression and refolding of Intein-PPSIG 
Intein-PPSIG was expressed in ER2566 cells as a � 8 7 kDa fusion protein. In cells 
transformed only with pTYB vector, a -59 kDa intein protein was expressed. Whole 
lysate was separated by centrifugation into soluble proteins and inclusion bodies, 
which contained Intein-PPSIG and was further refolded to restore its native 
conformation. Both Intein-PPSIG and intein were lighted up in the Western blotting 
analysis using 1:5000 anti-(chitin-binding domain) antiserum (anti-CBD) as primary 
antibody. M, unstained protein standards. 
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fusion partner in both fusion proteins. Centrifugation of the Thio-PPSIG and 
Intein-PPSIG whole lysate revealed that the recombinant fusion proteins was 
insoluble and were pelleted with inclusion bodies, implying that the fusion proteins 
might have been misfolded during the expression process. In order to restore the 
native form of PPSIG, the fusion protein was solubilized and refolded by dialysis. 
The refolded soluble thio-PPSIG was further purified by passing through a nickel 
column, which specifically retained the His-Patch thioredoxin tag, followed by elution 
with imidazole. 
3.3 Identification of recombinant Thio-PPSIG and 
Intein-PPSIG by mass spectrometry 
The identity of PPSIG fusion proteins were further investigated by its mass 
spectrum after trypsin digestion. Searching with the peptide masses obtained in the 
NCBI database identified the protein as the 0610039N19Rik protein (accession 
number: 15029943) which had the same sequence with the partial PPSIG used for 
cloning. Peptides recovered matched with the characteristic mass spectrum of 
trypsin-digested PPSIG. Thio-PPSIG was identified as PPSIG with a score of 240 
(significant threshold=78). Peptide fingerprinting results yielded 4 peptide peaks 
that matched with the trypsin digestion spectrum of the partial length of PPSIG (Table 
49 
3.1) with sequence coverage of 22.7%. Among the 4 peaks, the peak at m/z 
2123.0342 indicated on the spectrum (Figure 3.11) had intensity high enough for 
MS/MS sequencing, which gave a sequence of VESVTGGSPLTNKYYIAAPR 
(Figure 3.12) located at 157-176 region of the partial PPSIG amino acid sequence 
(Figure 3.13). When compared with the theoretical sequence 
VESVTGGSPLTNQYYLAAPR, changes in 2 amino acids were found (Q to K and L 
to I) and it was due to the coincidence of the fragment ion mass of the amino acid 
pairs. Similarly, Intein-PPSIG was also identified to be PPSIG with a score of 283 
(significant threshold=78) with 4 matching peptide peaks (Table 3.2) having a 
sequence coverage of 23.5%. The peak with mass 2123.0281 indicated on the mass 
spectrum (Figure 3.14) gave an MS/MS sequencing result of 
EVSVTGGSPLTNKYYLAAPR (Figure 3.15), which was located at the same 
position of the partial PPSIG (Figure 3.16). The change from Qto K was due to the 
same reason described above. There is also a change in amino acid order of V and E, 
which may be due to error during ion fragmentation of the first 2 amino acids at the 
N-terminal of the peptide. After confirming the identity of Thio-PPSIG and 
Intein-PPSIG, the fusion proteins were used for rabbit immunization for the 
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3.4 Preparation and characterization of Thio-PPSIG and 
Intein-PPSIG antisera 
To minimize bacterial contaminants from PPSIG fusion protein antigens, the 
fusion proteins were resolved on preparative SDS-PAGE. Coomassie blue staining 
showed a major band at � 4 3 kDa for Thio-PPSIG (Figure 3.17) and -87 kDa for 
Intein-PPSIG (Figure 3.18), and the protein bands were excised and homogenized in 
order to recover the antigen. After checking of antigen purity with mini SDS-PAGE, 
five boostings were made for each antigen. To determine the antigenicity of the 
antisera against PPSIG, the bleeding antisera and pre-immune serum were used as 
primary antibodies in Western blottings of recombinant Thio-PPSIG and Intein-PPSIG. 
Western blottings of Thio-PPSIG protein with Thio-PPSIG antiserum gave a strong 
immunoreactive band at -43 kDa, which was absent with pre-immune antiserum 
(Figure 3.19), suggesting the immunoreactivity was due to immunization with 
Thio-PPSIG. The thioredoxin tag in the pThioHis vector control lane was also 
lighted up, which was in agreement with the fact that thioredoxin protein was present 
on the antigen as a fusion partner, which lead to the generation of non-specific 
antibodies. As Intein-PPSIG antiserum is not antigenic to thioredoxin, only 
Thio-PPSIG but not thioredoxin was lighted up as a � 4 3 kDa protein using the same 
protein samples in the Western blotting. Similarly, antiserum against Intein-PPSIG 
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Preparation of Thio-PPSIG Semi-purified 
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Figure 3.17 Preparation of Thio-PPSIG antigen for rabbit immunization 
(priming to fifth boosting) 
Electrophoresis of � 1 mg of column-eluted refolded recombinant Thio-PPSIG on a 
10% SDS-PAGE gel for gel excision and homogenization in PBS. Semi-purified 
Thio-PPSIG, after checking for purity, was injected into rabbits for different boostings. 
CE, column-eluted refolded Thio-PPSIG P, semi-purified Thio-PPSIG M, 
SDS-PAGE protein standards. 
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Figure 3.18 Preparation of Intein-PPSIG antigen for rabbit immunization 
(priming to fifth boosting) 
Electrophoresis of � 1 mg of refolded recombinant Thio-PPSIG on an 8% SDS-PAGE 
gel for gel excision and homogenization. Semi-purified Thio-PPSIG, after checking 
for purity, was injected into rabbits for different boostings. RF, refolded 
Intein-PPSIG. P, semi-purified Intein-PPSIG. M, SDS-PAGE protein standards. 
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Figure 3.19 Antigenicity of Thio-PPSIG and Intein-PPSIG antisera (fifth 
bleeding) against Thio-PPSIG antigen 
Western blotting of different fractions of bacterial lysate containing Thio-PPSIG 
detected with 1:5000 Thio-PPSIG and Intein-PPSIG antisera. Thio-PPSIG lighted 
up an immunoreactive band of � 4 3 kDa corresponding to Thio-PPSIG in whole lysate, 
inclusion bodies, refolded proteins and column-eluted proteins，as well as the -16 kDa 
thioredoxin in the control lane transformed with pThioHis vector, which were absent 
with pre-immune serum. Intein-PPSIG antiserum lighted up the same 
immunoreactive band but not thioredoxin. M, prestained protein standards. 
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successfully detected both Intein-PPSIG fusion protein and intein protein in the pTYB 
vector control lane (Figure 3.20). When the same set of Intein-PPSIG protein was 
detected with Thio-PPSIG antiserum, only Intein-PPSIG but not the intein protein was 
lighted up, suggesting that the immunoreactivity was due to antigenicity against 
PPSIG protein. After confirming the antigenicity against bacterial recombinant 
PPSIG, Thio-PPSIG and Intein-PPSIG antisera were applied in Western blottings of 
tissue samples in order to identify the native PPSIG in mouse liver. 
3.5 Identification of native PPSIG and its induction 
pattern 
3.5.1 PPSIG was highly inducible upon 72-h starvation in a 
PPARa dependent manner 
Identification of PPSIG protein in Western blottings was assisted by observing 
its induction pattern by starvation in PPARa wild-type and knockout mice, which is 
expected to match with its mRNA induction pattern. Mouse liver, having a high 
constitutive expression level as well as a high induction level of PPSIG, was chosen 
for the investigation of both mRNA and protein induction. As a confirmation to 
previous findings in our lab, Northern blotting analysis of total liver RNA showed that 
PPSIG mRNA level was significantly induced upon 72-h starvation in wild-type mice 
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Figure 3.20 Antigenicity of Thio-PPSIG and Intein-PPSIG antisera (fifth 
bleeding) against Intein-PPSIG antigen 
Western blottings of different fractions of bacterial-expressed Intein-PPSIG. using 
Thio-PPSIG and Intein-PPSIG antisera with a titer of 1:5000. For Intein-PPSIG 
antiserum, detection of a � 8 7 kDa immunoreactive band corresponding to 
Intein-PPSIG was observed in whole lysate, incusion bodies and refolded proteins, 
accompanied by a -59 kDa intein protein. For Thio-PPSIG antiserum, only the � 8 7 
kDa immunoreactive band was lighted up. In each case, pre-immune serum was 
unable to light up any non-specific protein bands. M, prestained protein standards. 
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but not in knockout mice (Figure 3.21). The result was normalized with 18S and 
28S ribosomal RNA, which showed similar intensity in all lanes. Moving on to the 
induction pattern of PPSIG protein, liver samples were subjected to subcellular 
fractionation to yield endoplasmic reticulum in microsomal fraction, which contained 
PPSIG as predicted by previous experiments (Sun, paper submitted). A strong 
immunoreactive band of -60 kDa comparable to that of PPSIG was lighted up by both 
Thio-PPSIG and Intein-PPSIG antisera and was absent using pre-immune sera, 
suggesting that the band was contributed by antibodies against PPSIG (Figure 3.22). 
Although the band was smaller than the expected size of 67 kDa when compared with 
the molecular size marker of 64.2 kDa, it was believed to be due to the size 
discrepancy of prestained protein markers. Comparing the protein expression level 
in PPARa wild-type mice, the immunoreactive band was highly induced by starvation, 
consistently in all the three mice within a group. In the absence of PPARa, its 
constitutive expression level was lower than in wild-type mice and was slightly 
depressed by starvation in knockout mice. As the protein induction pattern was in 
coincidence with mRNA level in Northern blotting, the immunoreactive band was 
likely to represent native PPSIG. On the other hand, as the intensity of the 
immunoreactive band could be affected by the amount of microsomes loaded on each 
lane, it was monitored by calnexin, an integral membrane protein that localizes evenly 
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PPSIG mRNA is induced 
by 72 h starvation 
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Figure 3.21 PPSIG mRNA induction in liver (starvation experiment) using 
Northern blotting analysis 
Each lane contained 30 |ag total liver RNA from PPARa wild-type and knockout mice 
either fed or starved for 72 h. The �2000 bp band represented PPSIG mRNA, which 
had a stronger signal than its pre mRNA with a size of �3000 bp. Level of both 
transcripts was significantly induced upon 72 h starvation in wild-type mice but not in 
knockout mice. The 18S and 28S ribosomal RNA was shown for normalization to 
ensure equal RNA loading in each well. 
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starvation experiment 
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Figure 3.22 PPSIG protein induction in liver microsomes (starvation 
experiment) using Western blotting analysis 
Each lane contained 40 |ig of liver microsomes from PPARa wild-type and knockout 
mice either fed or starved for 72 h. Anti-calnexin antibody (1:2000) was 
co-incubated with pre-immune serum or antiserum, which lighted up a double band at 
-90 kDa. A -60 kDa immimoreactive band (expected to be -67 kDa) was lighted up 
by both Thio-PPSIG and Interin-PPSIG antisera (1:1000) but not by pre-immune 
serum (1:500). The band was highly induced in starved wild-type mice. Similar 
pattern was observed using anti-CYP4A antiserum (1:2000), which lighted up the � 5 5 
kDa CYP4A protein that is induced during starvation. M, prestained protein 
standards. 
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in the endoplasmic reticulum as performed by other research groups (Klett et al 2004) 
(Waugh et al. 2003). Upon co-incubation of anti-calnexin antiserum with PPSIG 
antisera, a ~90 kDa double band corresponding to calnexin was lighted up in all lanes 
having similar intensity with slight inconsistent variations. The observation of a 
double band was consistent with previous results (Klett et al 2004). Amount of 
microsomes, being proportional to that of calnexin, was therefore comparable in each 
lane, which ensured that it was fair to observe the protein expression level of the 
immimoreactive band from the Western blotting results. To observe whether 
induction of PPSIG was a consequence of starvation, Western blotting was performed 
using anti-CYP4A antiserum, which lighted up a band at � 4 0 kDa. As CYP4A 
protein was expected to be -55 kDa in size, it further shows that prestained protein 
marker underestimated the size of protein on the Western blottings. The corresponding 
CYP4A protein was a well-characterized PPARa target gene, which was significantly 
upregulated upon starvation. As CYP4A was found to be induced in wild-type mice 
but not in knockout mice, it was confident to deduce that the condition of starvation is 
optimum in activating PPARa. It added to the deduction that induction of PPSIG 
was PPARa-dependent and causally related to starvation. To further investigate the 
PPARa-dependence of PPSIG induction, its expression pattern was observed in mice 
treated with Wy-14,643, an exogenous PPARa ligand. 
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3.5.2 PPSIG showed slight induction upon 2-wk Wy-14,643 
treatment 
Being a well-documented exogenous ligand that could activate PPARa more 
specifically than starvation, 2-wk treatment with Wy-14,643 triggered PPSIG 
induction in a different way. Similar to the induction pattern in starvation 
experiment, the mRNA level of PPSIG was highly increased upon 2-wk Wy-14,643 
treatment in wild-type mice but not in knockout mice (Figure 3.23). However, 
PPSIG protein induction deviated from the induction pattern of mRNA. Consistent 
with both Thio-PPSIG antiserum and Intein-PPSIG antiserum, the same 
immunoreactive band was lighted up with similar intensity among the three mice in 
the same group (Figure 3.24). Similar to starvation treatment, constitutive 
expression level of PPSIG was higher in PPARa wild-type mice. However, the 
induction level of PPSIG was hardly observable in wild-type mice although its 
depression in knockout mice was consistent with starvation treatment. The 
credibility of PPSIG expression level was supported by the consistent level of 
calnexin double band in each lane. On the other hand, high induction level of PPSIG 
mRNA as well as the CYP4A protein in wild-type mice eliminated the possibility that 
Wy-14,643 treatment did not activate PPARa and thus could not induce PPSIG. 
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PPSIG mRNA is induced by 
2 wk Wy-14,643 treatment 
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Figure 3.23 PPSIG mRNA induction in liver (Wy-14,643 feeding experiment) 
using Northern blotting analysis 
Each lane contained 30 fig total liver RNA from PPARa wild-type and knockout mice 
either fed with control diet or 0.1 % (w/w) Wy-14,643 for 2 wk. Both �2000 bp and 
-3000 bp bands were highly induced by 2 wk Wy-14,643 treatment in wild-type mice. 
The same induction was not observed for knockout mice. The 18S and 28S 
ribosomal RNA showed that similar amount of RNA was loaded in each well. 
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Wy-14,643 feeding experiment 
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Figure 3.24 PPSIG protein induction in liver microsomes (Wy-14,643 feeding 
experiment) using Western blotting analysis 
Each lane contained 40 \ig of liver microsomes from PPARa wild-type and knockout 
mice either fed with control diet or 0.1% (w/w) Wy-14,643 for 2 wk. Anti-calnexin 
antibody (1:2000) lighted up a double band at � 9 0 kDa, when co-incubated with 
pre-immune serum or antiserum. A � 6 0 kDa immunoreactive band (expected to be 
� 6 7 kDa) was lighted up by both Thio-PPSIG and Interin-PPSIG antisera (1:1000) but 
not by pre-immune serum (1:500). No significant induction was observed in 
Wy-14,643 treated wild-type mice, despite high induction of the � 5  kDa CYP4A 
protein lighted up by anti-CYP4A antiserum (1:2000). M，prestained protein 
standards. 
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3.6 Confirmation of the specificity of PPSIG antiserum 
In order to confirm the specificity of PPSIG antiserum, immunoprecipitation 
of PPSIG with Thio-PPSIG antiserum was performed using liver microsomal fraction. 
Based on Western blotting results that expression level of PPSIG was higher in 
wild-type than in knockout mice，samples from wild-type mice in both treatments 
were chosen for immunoprecipitation. A strong immimoreactive band of size � 6 7 
kDa corresponding to PPSIG was lighted up by Thio-PPSIG antiserum in Western 
blotting of microsomes immunoprecipitated with the same antiserum (Figure 3.25). 
Absence of the same band in sample immunoprecipitated with pre-immune serum 
suggested that the band was specific to Thio-PPSIG. Two proteins bands below 
PPSIG represented the immunoglobulin heavy chain and light chain of the antibodies 
that pulled down PPSIG. Consistent with the induction pattern in total microsomes, 
PPSIG was highly induced by starvation in wild-type mice and slightly induced by 
Wy-14,643 treatment. In order to confirm the identity of the immimoreactive band 
being PPSIG, mass spectrometry was performed. With reference to the position of 
PPSIG on the Western blotting membrane, the protein band slightly above the 
immunoglobulin heavy chain was excised from the gel. After in-gel trypsin 
digestion and peptide extraction, the peptides recovered were analyzed by 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































order to match the peptide masses in the mass spectra with that of a known protein, 
the PMF data were submitted for searching in the NCBI database. For PPSIG 
immunoprecipitated from the microsome of mice fed with normal diet, the search 
result returned no protein that was similar to the sequence of PPSIG, which was 
explained by low abundance of PPSIG in the sample, as shown in the Western blotting. 
Amount of PPSIG was higher in starved samples and the protein identification gave a 
match with dXX-trans-13,14-dihydroretinol saturase at a protein score of 74 
(significance threshold=78). The 9 matching peptides covered 18.1% of the total 
amino acid sequence of PPSIG (Table 3.3). On the other hand, PPSIG from control 
mice or mice treated with Wy-14,643 were identified as dW-trans-13,14-dihydroretinol 
saturase with protein scores of 78 and 75 respectively (significance threshold=78). 
Nine matching peptide peaks were identified in the control sample showing sequence 
coverage of 19.0% (Table 3.4). The Wy-14,643 treated sample also gave 9 peptide 
peaks that matched with the trypsin digestion pattern of PPSIQ and the sequence 
coverage was 17.1% (Table 3.5). The identification of the immunoprecipitated 
protein to be PPSIG not only supported the specificity of Thio-PPSIG antiserum, but 
also confirmed that PPSIG is an authentic protein in mice liver that could be induced 
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Chapter 4 Discussion 
PPSIG is a novel PPARa target gene discovered in our laboratory, and current 
characterization of its functional role is directed by its PPARa-dependent inducibility. 
As its mRNA level was highly induced by either 72-h starvation or 2-wk Wy-14,643 
treatment as shown in FDD and Northern blottings, it is important to examine its 
induction pattern at protein level to determine if the protein levels match with the 
mRNA expression patterns in the starvation and Wy-14,643 treatments. By 
expressing recombinant PPSIG fusion proteins for rabbit immunization, we have 
raised polyclonal antisera against PPSIG, which can be used to identify the PPSIG 
protein and study its induction pattern in mouse liver tissue. 
To increase the chance of getting a specific antiserum, the immunization 
strategy involved two different antigens. Thioredoxin tag was added at the 
N-terminal of PPSIG while intein tag was added at the C-terminal. Thioredoxin was 
comparable in size to the truncated PPSIG while intein was much larger than PPSIG. 
Each fusion partner was expected to induce non-specific antibodies in the antiserum, 
as confirmed with the Western blotting results that the antisera lighted up also the lane 
transformed with vector only. The antigenicity against PPSIG was observed by the 
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immunoreactivity of each antiserum towards the recombinant protein with a different 
fusion partner. Thio-PPSIG antiserum lighted up Intein-PPSIG antigen and vice 
versa, suggesting that a considerable amount of antibodies against PPSIG was present 
in the antisera. It further showed that the size and position of the fusion partner did 
not obviously affect the immune response against PPSIG. Nevertheless, non-specific 
antibodies against the fusion partner limited the use of the antisera on experiments 
requiring a highly specific antibody, such as immunohistochemistry and affinity 
purification of PPSIG protein. If these experiments are to be carried out in the future, 
it may be better to obtain an antiserum using pure PPSIG protein as antigen. 
However, non-specific antibodies do not greatly affect the result in the current project. 
As the antisera are shown to be antigenic to PPSIG, it is suitable to apply them on the 
identification of native PPSIG in mouse liver. 
The native PPSIG was identified as a � 6 7 kDa protein in liver microsomes, 
where PPSIG is predicted to localize in. Its exact size would further be confirmed 
by N-terminal sequencing, in order to determine whether the signal peptide is retained 
at its N-terminal. Despite the presence of a fusion partner on its antigen, PPSIG was 
lighted up as a strong major band, indicating the specificity of the antisera. 
Detection of occasional minor bands on the Western blottings was either contributed 
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by the non-specific antibodies against the fusion partner or proteins having a similar 
conformation to PPSIG Observation of PPSIG was assisted by the induction pattern 
by starvation and Wy-14,643 in PPARa wild-type and knockout mice. As the 
mRNA expression can be induced by both starvation and Wy-14,643 feeding, it was 
expected that the protein induction pattern would match with mRNA level. PPSIG 
protein was obviously induced by starvation in PPARa, which strengthens the 
conclusion that the -67 kDa immunogenic band was PPSIG. However, the protein 
induction pattern by Wy-14,643 deviated from the mRNA induction pattern although 
the same protein was identified from the Western blotting. Only slight induction of 
PPSIG was observed in wild-type mice fed with Wy-14,643 for 2 wk. 
To confirm the immunogenic band as PPSIG, mass spectrometry was 
performed followed by immimprecipitation with Thio-PPSIG antiserum. Being 
well-characterized at its mRNA level, there has not been solid identification of native 
PPSIG based on it protein sequence. Mass spectrometry analysis followed by 
immunoprecipitation gave a hit of dXX-trans-13,14-dihydroretinol saturase in 3 out of 4 
samples. PPSIG was identified in wild-type mice starved for 72 h, fed with control 
diet and fed with 0.1% (w/w) Wy-14,643 for 2 wk. The major limitation of 
immunoprecipitation was the contamination of PPSIG with rabbit immunoglobulin 
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heavy chain, which is especially significant for PPSIG having similar size with the 
heavy chain. In addition, low amount of PPSIG recovered after 
immunoprecipitation makes MS/MS sequencing not feasible and resulted in a 
relatively low protein score. Nevertheless, the consistent identification of PPSIG in 
3 samples mentioned above should lead to a reliable conclusion that the major 
immunogenic band lighted up by PPSIG antisera corresponded to PPSIG. It 
provides substantial proof that PPSIG, with its protein sequence derived from its 
mRNA, is not only a hypothetical protein, which further supports our interpretation of 
PPSIG induction in mouse liver microsomes. 
PPSIG, being found to be inducible by starvation in a PPARa-dependent 
manner at its mRNA level, is believed to play an important role in lipid metabolism. 
Having its starvation inducibility confirmed by Western blotting, it is reasonable to 
predict its function with reference to a starved condition, where lipids are broken 
down into fatty acids for energy production. Although starvation also triggers a 
change in protein expression profile in the body, a direct relationship should be drawn 
between PPSIG induction and generation of fatty acids, which are endogenous 
PPARa ligands. A number of PPARa-regulated genes with different functions have 
been reported to be inducible by starvation and take part in lipid metabolism. Those 
84 
having a peroxisome proliferator response element report are usually inducible also 
by exogenous PPARa ligands such as fibrates, so the protein induction pattern of 
PPSIG by Wy-14,643 was investigated. 
Unexpectedly, treatment of Wy-14,643 failed to induce expression of PPSIG 
protein. From Northern blotting results, the mRNA level of PPSIG was induced by 
2-wk treatment with Wy-14,643, which belongs to a group of hypolipidemic drug 
used to lower blood cholesterol level. Being structurally similar to fatty acids, it is a 
ligand for PPARa that activates the transcription of PPARa target genes. However, 
failure of causing a corresponding induction of PPSIG protein implied that the 
translational and post-translational steps involve a more complicated mechanism. 
This phenomenon has been reported for carbonic anhydrase IX, which was suggested 
to have low translation efficiency (Hilvo et al 2004). It is not likely for PPSIG, as 
there is considerable expression of PPSIG in PPARa wild-type mice fed with normal 
diet. However, it is possible that excess mRNA is degraded by microRNAs, which 
has been shown to regulate the expression of a number of genes (Carthew 2006). 
Induction of PPSIG protein during starvation but not Wy-14,643 treatment suggested 
that the induction of microRNAs against PPSIG mRNA may be dependant on the 
presence of Wy-14,643. However, as the biological role and mechanism of 
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microRNAs are not fully characterized, it would be difficult to draw a conclusion on 
whether microRNAs did take part in the regulation of PPSIG mRNA level. In order 
to further examine the effect of Wy-14,643 treatment to PPSIG protein induction, 
feeding the mice with different dosage of Wy-14,643 for different time periods may 
be considered. On the other hand, localization to other cellular compartments is not 
expected, as shown by GFP-PPSIG fusion protein in mammalian cells. As PPSIG 
was predicted to contain a secretory signal peptide, it is possible that the PPSIG 
synthesized did not stay in endoplasmic reticulum and is secreted outside the cells. 
It is also possible that the nascent PPSIG chain is misfolded and being degraded by 
the quality control machinery in the endoplasmic reticulum (Ellgaard and Helenius 
2003). Degradation and removal of misfolded protein is assisted by the formation of 
inter-chain disulphide bonds (Molinari et al 2002), which may also contributed to the 
formation of inclusion bodies during expression in E. coli. It is not surprising 
because Wy-14,643 was applied to specifically activate PPARa, and may cause the 
expression of different proteins that destabilizes or aggregate PPSIG. No matter why 
PPSIG protein failed to be induced by Wy-14,643 treatment, it is strongly believed 
that PPSIG was an important protein during starvation. In order to predict the role of 
PPSIG during starvation, it is important to compare its induction pattern and 
subcellular localization with other well-characterized PPARa target genes. 
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PPSIG shows similar induction pattern to pyruvate dehydrogenase kinase 4 
(PDK-4). While its mRNA level can be induced by both starvation and Wy-14,643 
treatment, its protein induction level is much higher during starvation (Holness et al 
2003; Sugden et al 2002). It has been extensively studied to inhibit the activity of 
pyruvate dehydrogenase, a key enzyme in glucose metabolism which catalyzes the 
conversion of pyruvate to acetyl-CoA for production of energy in the TCA cycle. 
Therefore, activation of PPARa shifts the energy homeostasis equilibrium from 
glucose oxidation to gluconeogenesis, sparing glucose for utilization by the brain. 
Considering the biological function of PDK-4, starvation would be a more reasonable 
inducer, as in the case of PPSIG However, PDK-4 differs from PPSIG in terms of 
its tissue distribution. It is highly inducible in skeletal muscle after 24 hr of 
starvation and decline gradually afterwards (Li et al. 2006). In addition, it can be 
induced by high fat diet (Holness et al. 2000), which does not affect the expression of 
PPSIG (data unpublished). 
Another PPARa-inducible gene is the acyl-CoA oxidase, which catalyzes the 
dehydrogenation of fatty acyl-CoA to 广ra似-2-enoyl-CoA, a committing step into 
peroxisomal p-oxidation. It helps the production of energy from fatty acids during 
starvation. With the identification of a peroxisome proliferator responsive element, 
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its induction in both mRNA and protein level is believed to be PPARa-mediated 
(Tugwood et al 1992). Its hydrogen withdrawing ability may be due an FAD 
binding site (Tokuoka et al 2006), which is also present in PPSIG as predicted from 
its amino acid sequence. Therefore, it is likely for PPSIG to possess dehydrogenase 
activity. However, as PPSIG is localized in the endoplasmic reticulum, it is 
necessary to compare its inducibility with an enzyme from the same subcellular 
compartment. 
The cytochrome P450 4A enzymes localize extensively in the smooth 
endoplasmic reticulum and are responsible for fatty acid co-hydroxylation (He et al 
2005). After oxidizing the carbon most distant from the carboxyl group, the 
resulting dicarboxylic fatty acids then undergo normal peroxisomal p-oxidation. 
Therefore, the enzymes are also responsible for energy production using fatty acids 
during starvation. From previous studies of other research groups and our Western 
results, its mRNA and protein level is inducible by starvation and Wy-14,643 
treatment (Kroetz et al. 1998)，and it is a PPARa target gene with the PPRE sequence 
discovered (Johnson et al 1996). As it localizes with PPSIG, it is possible that they 
are cooperatively involved in the same pathway in fatty acid catabolism during 
activation of PPARa by starvation. 
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After the identification of PPSIG to be di\\-trans-\?>M dihydroretinol saturase 
in 2004, the group has claimed to unveil its conversion of all-/r<ms-retinol to 
13,14-dihydroretinol by the addition of 2 double bonds (Moise et al 2004). The 
discovery is in line with the sequence analysis that PPSIG contains an FAD binding 
domain and possess dehydrogenase activity. However, to understand more about its 
physiological role, a causal linkage is to be drawn from starvation to either clearance 
of all-fra«5-retinol or production of 13,14-dihydroretinol. All-rra«5-retinol, the 
dietary form of vitamin A is stored in liver and is transported to different parts of the 
body. Considering its role as an important nutrient, degradation of vitamin A during 
starvation is not likely. It is however possible that during starvation, PPSIG helps 
produce energy by utilizing vitamin A that possesses carbon chains like fatty acids 
with a novel pathway. On the other hand, saturation of the double bond may also 
facilitate the binding of vitamin A to transporter proteins that carried them to different 
tissues. For 13,14-dihydroretinol, as it is a newly discovered metabolite with 
unknown biological function, it would be difficult to predict its role during starvation. 
After all, the in vitro reaction might not be the physiological pathway PPSIG is 
involved in. Based on our induction results, we believe that PPSIG plays a more 
important role in fatty acids catabolism. Future characterization of PPSIG helps 
identify the induction mechanism and function of PPSIG. After over-expressing 
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PPSIG in mammalian cells, polyunsaturated fatty acids of different lengths is to be 
added into the medium to test for its substrate specificity. By finding the fatty acid 
that PPSIG can cause a change in its structure, we hope to identify the physiological 
substrate of PPSIG. Besides over-expressing PPSIG, activity of PPSIG may be 
knocked down by RNA interference and the production of knockout mice, in order to 
further speculate the function of PPSIG. 
In conclusion, the polyclonal antisera produced were antigenic to recombinant 
PPSIG and were used to identify native PPSIG from liver microsome, as confirmed 
by its inducibility by starvation. Although Wy-14,643 feeding failed to cause a 
corresponding induction in PPSIG protein, PPSIG is believed to participate in 
important metabolic pathways during starvation in a PPARa-dependent manner, in 
addition to the previously reported saturase activity. With future studies on tissue 
distribution and substrate specificity of PPSIG protein, we hope to understand more 
about the role of this novel PPARa target gene. 
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Appendix A: Deduced amino acid sequences of PPSIG fusion 
proteins 
Al: Deduced amino acid sequence of Thio-PPSIG from pThioHis-PPSIG 
plasmid (Predicted size: 43 kDa) 
GACGAAAGGGCCTCG TGATACGCCTATTTT TATAGGTTAATGTCA TGATAATAATGGTTT CTTAGACGTCAGGTG GCACTTTTCGGGGAA 90 
ATGTGCGCGGAACCC CTATTTGTTTATTTT TCTAAATACATTCAA ATATGTATCCGCTCA TGAGACAATAACCCT GATAAATGCTTCAAT 180 
AATATTGAAAAAGGA AGAGTATGAGTATTC AACATTTCCGTGTCG CCCTTATTCCCTTTT TTGCGGCATTTTGCC TTCCTGTTTTTGCTC 270 
ACCCAGAAACGCTGG TGAAAGTAAAAGATG CTGAAGATCAGTTGG GTGCACGAGTGGGTT ACATCGAACTGGATC TCAACAGCGGTAAGA 360 
TCCTTGAGAGTTTTC GCCCCGAAGAACGTT TTCCAATGATGAGCA CTTTTAAAGTTCTGC TATGTGGCGCGGTAT TATCCCGTATTGACG 450 
CCGGGCAAGAGCAAC TCGGTCGCCGCATAC ACTATTCTCAGAATG ACTTGGTTGAGTACT CACCAGTCACAGAAA AGCATCTTACGGATG 540 
GCATGACAGTAAGAG AATTATGCAGTGCTG CCATAACCATGAGTG ATAACACTGCGGCCA ACTTACTTCTGACAA CGATCGGAGGACCGA 630 
AGGAGCTAACCGCTT TTTTGCACAACATGG GGGATCATGTAACTC GCCTTGATCGTTGGG AACCGGAGCTGAATG AAGCCATACCAAACG 720 
ACGAGCGTGACACCA CGATGCCTGTAGCAA TGGCAACAACGTTGC GCAAACTATTAACTG GCGAACTACTTACTC TAGCTTCCCGGCAAC 810 
AATTAATAGACTGGA TGGAGGCGGATAAAG TTGCAGGACCACTTC TGCGCTCGGCCCTTC CGGCTGGCTGGTTTA TTGCTGATAAATCTG 900 
GAGCCGGTGAGCGTG GGTCTCGCGGTATCA TTGCAGCACTGGGGC CAGATGGTAAGCCCT CCCGTATCGTAGTTA TCTACACGACGGGGA 990 
GTCAGGCAACTATGG ATGAACGAAATAGAC AGATCGCTGAGATAG GTGCCTCACTGATTA AGCATTGGTAACTGT CAGACCAAGTTTACT 1080 
CATATATACTTTAGA TTGATTTAAAACTTC ATTTTTAATTTAAAA GGATCTAGGTGAAGA TCCTTTTTGATAATC TCATGACCAAAATCC 1170 
CTTAACGTGAGTTTT CGTTCCACTGAGCGT CAGACCCCGTAGAAA AGATCAAAGGATCTT CTTGAGATCCTTTTT TTCTGCGCGTAATCT 1260 
GCTGCTTGCAAACAA AAAAACCACCGCTAC CAGCGGTGGTTTGTT TGCCGGATCAAGAGC TACCAACTCTTTTTC CGAAGGTAACTGGCT 1350 
TCAGCAGAGCGCAGA TACCAAATACTGTCC TTCTAGTGTAGCCGT AGTTAGGCCACCACT TCAAGAACTCTGTAG CACCGCCTACATACC 1440 
TCGCTCTGCTAATCC TGTTACCAGTGGCTG CTGCCAGTGGCGATA AGTCGTGTCTTACCG GGTTGGACTCAAGAC GATAGTTACCGGATA 1530 
AGGCGCAGCGGTCGG GCTGAACGGGGGGTT CGTGCACACAGCCCA GCTTGGAGCGAACGA CCTACACCGAACTGA GATACCTACAGCGTG 1620 
AGCATTGAGAAAGCG CCACGCTTCCCGAAG GGAGAAAGGCGGACA GGTATCCGGTAAGCG GCAGGGTCGGAACAG GAGAGCGCACGAGGG 1710 
AGCTTCCAGGGGGAA ACGCCTGGTATCTTT ATAGTCCTGTCGGGT TTCGCCACCTCTGAC TTGAGCGTCGATTTT TGTGATGCTCGTCAG 1800 
GGGGGCGGAGCCTAT GGAAAAACGCCAGCA ACGCGGCCTTTTTAC GGTTCCTGGCCTTTT GCTGGCCTTTTGCTC ACATGTTTACGTTGA 1890 
CACCATCGAATGGTG CAAAACCTTTCGCGG TATGGCATGATAGCG CCCGGAAGAGAGTCA ATTCAGGGTGGTGAA TGTGAAACCAGTAAC 1980 
GTTATACGATGTCGC AGAGTATGCCGGTGT CTCTTATCAGACCGT TTCCCGCGTGGTGAA CCAGGCCAGCCACGT TTCTGCGAAAACGCG 2070 
GGAAAAAGTGGAAGC GGCGATGGCGGAGCT GAATTACATTCCCAA CCGCGTGGCACAACA ACTGGCGGGCAAACA GTCGTTGCTGATTGG 2160 
CGTTGCCACCTCCAG TCTGGCCCTGCACGC GCCGTCGCAAATTGT CGCGGCGATTAAATC TCGCGCCGATCAACT GGGTGCCAGCGTGGT 2250 
GGTGTCGATGGTAGA ACGAAGCGGCGTCGA AGCCTGTAAAGCGGC GGTGCACAATCTTCT CGCGCAACGCGTCAG TGGGCTGATCATTAA 2340 
CTATCCGCTGGATGA CCAGGATGCCATTGC TGTGGAAGCTGCCTG CACTAATGTTCCGGC GTTATTTCTTGATGT CTCTGACCAGACACC 2430 
CATCAACAGTATTAT TTTCTCCCATGAAGA CGGTACGCGACTGGG CGTGGAGCATCTGGT CGCATTGGGTCACCA GCAAATCGCGCTGTT 2520 
AGCGGGCCCATTAAG TTCTGTCTCGGCGCG TCTGCGTCTGGCTGG CTGGCATAAATATCT CACTCGCAATCAAAT TCAGCCGATAGCGGA 2610 
ACGGGAAGGCGACTG GAGTGCCATGTCCGG TTTTCAACAAACCAT GCAAATGCTGAATGA GGGCATCGTTCCCAC TGCGATGCTGGTTGC 2700 
CAACGATCAGATGGC GCTGGGCGCAATGCG CGCCATTACCGAGTC CGGGCTGCGCGTTGG TGCGGATATCTCGGT AGTGGGATACGACGA 2790 
TACCGAAGACAGCTC ATGTTATATCCCGCC GTCAACCACCATCAA ACAGGATTTTCGCCT GCTGGGGCAAACCAG CGTGGACCGCTTGCT 2880 
GCAACTCTCTCAGGG CCAGGCGGTGAAGGG CAATCAGCTGTTGCC CGTCTCACTGGTGAA AAGAAAAACCACCCT GGCGCCCAATACGCA 2970 
AACCGCCTCTCCCCG CGCGTTGGCCGATTC ATTAATGCAGCTGGC ACGACAGGTTTCCCG ACTGGAAAGCGGGCA GTGAGCGCAACGCAA 3060 
TTAATGTGAGTTAGC GCGAATTGATCTGGT TTGACAGCTTATCAT CGACTGCACGGTGCA CCAATGCTTCTGGCG TCAGGCAGCCATCGG 3150 
AAGCTGTGGTATGGC TGTGCAGGTCGTAAA TCACTGCATAATTCG TGTCGCTCAAGGCGC ACTCCCGTTCTGGAT AATGTTTTTTGCGCC 3240 
GACATCATAACGGTT CTGGCAAATATTCTG AAATGAGCTGTTGAC AATTAATCATCCGGC TCGTATAATGTGTGG AATTGTGAGCGGATA 3330 
ACAATTTCACACAGG AAACAGCGCCGCTGA GAAAAAGCGAAGCGG CACTGCTCTTTAACA ATTTATCAGACAATC TGTGTGGGCACTCGA 3420 
M S D K I I H L T D D S F 
CCGGAATTATCGATT AACTTTATTATTAAA AATTAAAGAGGTATA TACATATGTCTGATA AAATTATTCATCTGA CTGATGATTCTTTTG 3510 
D T D V L K A D G A I L V D F W A H W C G P C K M I A P I L 
ATACTGATGTACTTA AGGCAGATGGTGCAA TCCTGGTTGATTTCT GGGCACACTGGTGCG GTCCGTGCAAAATGA TCGCTCCGATTCTGG 3600 
D E I A D E Y Q G K L T V A K L N I D H N P G T A P K Y G I 
ATGAAATCGCTGACG AATATCAGGGCAAAC TGACCGTTGCAAAAC TGAACATCGATCACA ACCCGGGCACTGCGC CGAAATATGGCATCC 3690 
R G I P T L L L F K N G E V A A T K V G A L S K G Q L K E F 
GTGGTATCCCGACTC TGCTGCTGTTCAAAA ACGGTGAAGTGGCGG CAACCAAAGTGGGTG CACTGTCTAAAGGTC AGTTGAAAGAGTTCC 3780 
L D A N L A G S G S G D D D D K V P G M L S S R S S N S A G 
TCGACGCTAACCTGG CCGGCTCTGGATCCG GTGATGACGATGACA AGGTACCTGGCATGC TGAGCTCGAGATCTT CGAATTCCGCGGGGA 3870 
99 
N A G M F N T Y Q H L L P E T V R H L P D V K K Q L A M V R 
ATGCGGGAATGTTCA ATACCTATCAGCACT TGTTGCCAGAGACCG TCCGCCATCTGCCAG ATGTGAAGAAGCAGC TGGCGATGGTAAGGC 3960 
P G L S M L S I F I C L K G T K E D L K L Q S T N Y Y V Y F 
CTGGTCTGAGCATGC TCTCAATCTTCATCT GTCTGAAAGGCACCA AGGAGGACCTGAAGC TTCAGTCCACCAACT ACTATGTTTATTTTG 4050 
D T D V D K A M E R Y V S M P K E K A P E H I P L L F I A F 
ACACAGACGTGGACA AAGCGATGGAGCGCT ATGTCTCTATGCCCA AGGAAAAGGCTCCAG AACACATTCCCCTTC TCTTCATTGCCTTCC 4140 
P S S K D P T W E E R F P D R S T M T A L V P M A F E W F E 
CATCAAGCAAGGATC CAACCTGGGAGGAGC GATTCCCAGACCGAT CCACAATGACTGCGC TGGTACCCATGGCCT TTGAATGGTTCGAGG 4230 
E W Q E E P K G K R G V D Y E T P K N A F V E A S M S V I M 
AGTGGCAGGAGGAGC CAAAGGGCAAGCGTG GTGTTGACTATGAGA CCCCCAAAAATGCCT TCGTGGAAGCCTCTA TGTCGGTGATCATGG 4320 
E L F P R L E G K V E S V T G G S P L T N Q Y Y L A A P R G 
AACTGTTCCCACGGC TGGAGGGCAAGGTGG AGAGTGTGACTGGAG GGTCACCACTGACCA ACCAGTACTATCTGG CTGCACCCCGAGGAG 4410 
A T Y G A D H D L A R L H P H A M A S I R A Q T P I P N L Y 
CTACCTATGGAGCTG ACCATGACTTGGCTC GGCTGCATCCTCATG CAATGGCTTCCATAA GAGCCCAAACCCCCA TCCCCAACCTCTACC 4500 
L T G Q D I F T C G L M G A L Q G A L L C S S A I L K R N L 
TGACAGGCCAAGATA TCTTCACCTGTGGGC TGATGGGGGCCCTGC AGGGGGCCTTGCTGT GCAGCAGTGCCATCC TGAAACGGAACTTGT 4590 
Y S D L Q A L G S K V K A Q K K K M 
ACTCAGATCTGCAGG CTCTTGGCTCAAAGG TCAAGGCACAAAAGA AGAAGATGTAGTCCG TTCAGAGAAGCTCTA GAGTCGACCTGCAGT 4680 
AATCGTACAGGGTAG TACA AATAAAAAAG GCACG TCAGATGAC GTGCCTTTTTTCTTG TGAGCAGTAAGCTTG GCACTGGCCGTCGTT 4770 
TTACAACGTCGTGAC TGGGAAAACCCTGGC GTTACCCAACTTAAT CGCCTTGCAGCACAT CCCCCTTTCGCCAGC TGGCGTAATAGCGAA 4860 
GAGGCCCGCACCGAT CGCCCTTCCCAACAG TTGCGCAGCCTGAAT GGCGAATGGCGCCTG ATGCGGTATTTTCTC CTTACGCATCTGTGC 4950 
GGTATTTCACACCGC ATATATGGTGCACTC TCAGTACAATCTGCT CTGATGCCGCATAGT TAAGCCAGCCCCGAC ACCCGCCAACACCCG 5040 
CTGACGCGCCCTGAC GGGCTTGTCTGCTCC CGGCATCCGCTTACA GACAAGCTGTGACCG TCTCCGGGAGCTGCA TGTGTCAGAGGTTTT 5130 
CACCGTCATCACCGA AACGCGCGA 5154 
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A2: Deduced amino acid sequence of Intein-PPSIG from pTYB-PPSIG 
plasmid (Predicted size: 87 kDa) 
AACTACGTCAGGTGG CACTTTTCGGGGAAA TGTGCGCGGAACCCC TATTTGTTTATTTTT CTAAATACATTCAAA TATGTATCCGCTCAT 90 
GAGACAATAACCCTG ATAAATGCTTCAATA ATATTGAAAAAGGAA GAGTATGAGTATTCA ACATTTCCGTGTCGC CCTTATTCCCTTTTT 180 
TGCGGCATTTTGCCT TCCTGTTTTTGCTCA CCCAGAAACGCTGGT GAAAGTAAAAGATGC TGAAGATCAGTTGGG TGCACGAGTGGGTTA 270 
CATCGAACTGGATCT CAACAGCGGTAAGAT CCTTGAGAGTTTTCG CCCCGAAGAACGTTC TCCAATGATGAGCAC TTTTAAAGTTCTGCT 360 
ATGTGGCGCGGTATT ATCCCGTGTTGACGC CGGGCAAGAGCAACT CGGTCGCCGCATACA CTATTCTCAGAATGA CTTGGTTGAGTACTC 450 
ACCAGTCACAGAAAA GCATCTTACGGATGG CATGACAGTAAGAGA ATTATGCAGTGCTGC CATAACCATGAGTGA TAACACTGCGGCCAA 540 
CTTACTTCTGACAAC GATCGGAGGACCGAA GGAGCTAACCGCTTT TTTGCACAACATGGG GGATCATGTAACTCG CCTTGATCGTTGGGA 630 
ACCGGAGCTGAATGA AGCCATACCAAACGA CGAGCGTGACACCAC GATGCCTGTAGCAAT GGCAACAACGTTGCG CAAACTATTAACTGG 720 
CGAACTACTTACTCT AGCTTCCCGGCAACA ATTAATAGACTGGAT GGAGGCGGATAAAGT TGCAGGACCACTTCT GCGCTCGGCCCTTCC 810 
GGCTGGCTGGTTTAT TGCTGATAAATCTGG AGCCGGTGAGCGTGG GTCTCGCGGTATCAT TGCAGCACTGGGGCC AGATGGTAAGCCCTC 900 
CCGTATCGTAGTTAT CTACACGACGGGGAG TCAGGCAACTATGGA TGAACGAAATAGACA GATCGCTGAGATAGG TGCCTCACTGATTAA 990 
GCATTGGTAACTGTC AGACCAAGTTTACTC ATATATACTTTAGAT TGATTTACCCCGGTT GATAATCAGAAAAGC CCCAAAAACAGGAAG 1080 
ATTGTATAAGCAAAT ATTTAAATTGTAAAC GTTAATATTTTGTTA AAATTCGCGTTAAAT TTTTGTTAAATCAGC TCATTTTTTAACCAA 1170 
TAGGCCGAAATCGGC AAAATCCCTTATAAA TCAAAAGAATAGCCC GAGATAGGGTTGAGT GTTGTTCCAGTTTGG AACAAGAGTCCACTA 1260 
TTAAAGAACGTGGAC TCCAACGTCAAAGGG CGAAAAACCGTCTAT CAGGGCGATGGCCCA CTACGTGAACCATCA CCCAAATCAAGTTTT 1350 
TTGGGGTCGAGGTGC CGTAAAGCACTAAAT CGGAACCCTAAAGGG AGCCCCCGATTTAGA GCTTGACGGGGAAAG CCGGCGAACGTGGCG 1440 
AGAAAGGAAGGGAAG AAAGCGAAAGGAGCG GGCGCTAGGGCGCTG GCAAGTGTAGCGGTC ACGCTGCGCGTAACC ACCACACCCGCCGCG 1530 
CTTAATGCGCCGCTA CAGGGCGCGTAAAAG GATCTAGGTGAAGAT CCTTTTTGATAATCT CATGACCAAAATCCC TTAACGTGAGTTTTC 1620 
GTTCCACTGAGCGTC AGACCCCGTAGAAAA GATCAAAGGATCTTC TTGAGATCCTTTTTT TCTGCGCGTAATCTG CTGCTTGCAAACAAA 1710 
AAAACCACCGCTACC AGCGGTGGTTTGTTT GCCGGATCAAGAGCT ACCAACTCTTTTTCC GAAGGTAACTGGCTT CAGCAGAGCGCAGAT 1800 
ACCAAATACTGTCCT TCTAGTGTAGCCGTA GTTAGGCCACCACTT CAAGAACTCTGTAGC ACCGCCTACATACCT CGCTCTGCTAATCCT 1890 
GTTACCAGTGGCTGC TGCCAGTGGCGATAA GTCGTGTCTTACCGG GTTGGACTCAAGACG ATAGTTACCGGATAA GGCGCAGCGGTCGGG 1980 
CTGAACGGGGGGTTC GTGCACACAGCCCAG CTTGGAGCGAACGAC CTACACCGAACTGAG ATACCTACAGCGTGA GCTATGAGAAAGCGC 2070 
CACGCTTCCCGAAGG GAGAAAGGCGGACAG GTATCCGGTAAGCGG CAGGGTCC3GAACAGG AGAGCGCACGAGGGA GCTTCCAGGGGGAAA 2160 
CGCCTGGTATCTTTA TAGTCCTGTCGGGTT TCGCCACCTCTGACT TGAGCGTCGATTTTT GTGATGCTCGTCAGG GGGGCGGAGCCTATG 2250 
GAAAAACGCCAGCAA CGCGGCCTTTTTACG GTTCCTGGCCTTTTG CTGGCCTTTTGCTCA CATGTTCTTTCCTGC GTTATCCCCTGATTC 234 0 
TGTGGATAACCGTAT TACCGCCTTTGAGTG AGCTGATACCGCTCG CCGCAGCCGAACGAC CGAGCGCAGCGAGTC AGTGAGCGAGGAAGC 24 30 
TATGGTGCACTCTCA GTACAATCTGCTCTG ATGCCGCATAGTTAA GCCAGTATACACTCC GCTATCGCTACGTGA CTGGGTCATGGCTGC 2520 
GCCCCGACACCCGCC AACACCCGCTGACGC GCCCTGACGGGCTTG TCTGCTCCCGGCATC CGCTTACAGACAAGC TGTGACCGTCTCCGG 2610 
GAGCTGCATGTGTCA GAGGTTTTCACCGTC ATCACCGAAACGCGC GAGGCAGCTGCGGTA AAGCTCATCAGCGTG GTCGTGCAGCGATTC 2700 
ACAGATGTCTGCCTG TTCATCCGCGTCCAG CTCGTTGAGTTTCTC CAGAAGCGTTAATGT CTGGCTTCTGATAAA GCGGGCCATGTTAAG 2790 
GGCGGTTTTTTCCTG TTTGGTCACTGATGC CTCCGTGTAAGGGGG ATTTCTGTTCATGGG GGTAATGATACCGAT GAAACGAGAGAGGAT 2880 
GCTCACGATACGGGT TACTGATGATGAACA TGCCCGGTTACTGGA ACGTTGTGAGGGTAA ACAACTGGCGGTATG GATGCGGCGGGACCA 2970 
GAGAAAAATCACTCA GGGTCAATGCCAGCC GAACGCCAGCAAGAC GTAGCCCAGCGCGTC GGCCGCCATGCCGGC GATAATGGCCTGCTT 3060 
CTCGCCGAAACGTTT GGTGGCGGGACCAGT GACGAAGGCTTGAGC GAGGGCGTGCAAGAT TCCGAATACCGCAAG CGACAGGCCGATCAT 3150 
CGTCGCGCTCCAGCG AAAGCGGTCCTCGCC GAAAATGACCCAGAG CGCTGCCGGCACCTG TCCTACGAGTTGCAT GATAAAGAAGACAGT 3240 
CATAAGTGCGGCGAC GATAGTCATGCCCCG CGCCCACCGGAAGGA GCTGACTGGGTTGAA GGCTCTCAAGGGCAT CGGTCGAGATCCCGG 3330 
TGCCTAATGAGTGAG CTAACTTACATTAAT TGCGTTGCGCTCACT GCCCGCTTTCCAGTC GGGAAACCTGTCGTG CCAGCTGCATTAATG 3420 
AATCGGCCAACGCGC GGGGAGAGGCGGTTT GCGTATTGGGCGCCA GGGTGGTTTTTCTTT TCACCAGTGAGACGG GCAACAGCTGATTGC 3510 
CCTTCACCGCCTGGC CCTGAGAGAGTTGCA GCAAGCGGTCCACGC TGGTTTGCCCCAGCA GGCGAAAATCCTGTT TGATGGTGGTTAACG 3600 
GCGGGATATAACATG AGCTGTCTTCGGTAT CGTCGTATCCCACTA CCGAGATATCCGCAC CAACGCGCAGCCCGG ACTCGGTAATGGCGC 3690 
GCATTGCGCCCAGCG CCATCTGATCGTTGG CAACCAGCATCGCAG TGGGAACGATGCCCT CATTCAGCATTTGCA TGGTTTGTTGAAAAC 3780 
CGGACATGGCACTCC AGTCGCCTTCCCGTT CCGCTATCGGCTGAA TTTGATTGCGAGTGA GATATTTATGCCAGC CAGCCAGACGCAGAC 3870 
GCGCCGAGACAGAAC TTAATGGGCCCGCTA ACAGCGCGATTTGCT GGTGACCCAATGCGA CCAGATGCTCCACGC CCAGTCGCGTACCGT 3960 
CTTCATGGGAGAAAA TAATACTGTTGATGG GTGTCTGGTCAGAGA CATCAAGAAATAACG CCGGAACATTAGTGC AGGCAGCTTCCACAG 4050 
CAATGGCATCCTGGT CATCCAGCGGATAGT TAATGATCAGCCCAC TGACGCGTTGCGCGA GAAGATTGTGCACCG CCGCTTTACAGGCTT 4140 
CGACGCCGCTTCGTT CTACCATCGACACCA CCACGCTGGCACCCA GTTGATCGGCGCGAG ATTTAATCGCCGCGA CAATTTGCGACGGCG 4230 
CGTGCAGGGCCAGAC TGGAGGTGGCAACGC CAATCAGCAACGACT GTTTGCCCGCCAGTT GTTGTGCCACGCGGT TGGGAATGTAATTCA 4 3 2 0 
GCTCCGCCATCGCCG CTTCCACTTTTTCCC GCGTTTTCGCAGAAA CGTGGCTGGCCTGGT TCACCACGCGGGAAA CGGTCTGATAAGAGA 4410 
CACCGGCATACTCTG CGACATCGTATAACG TTACTGGTTTCACAT TCACCACCCTGAATT GACTCTCTTCCGGGC GCTATCATGCCATAC 4500 
CGCGAAAGGTTTTGC GCCATTCGATGGTGT CCGGGATCTCGACGC TCTCCCTTATGCGAC TCCTGCATTAGGAAG CAGCCCAGTAGTAGG 4590 
TTGAGGCCGTTGAGC ACCGCCGCCGCAAGG AATGGTGCATGCCGG CATGCCGCCCTTTCG TCTTCAAGAATTAAT TCCCAATTCCCCAGG 4680 
CATCAAATAAAACGA AAGGCTCAGTCGAAA GACTGGGCCTTTCGT TTTATCTGTTGTTTG TCGGTGAACGCTCTC CTGAGTAGGACAAAT 4770 
101 
CCGCCGGGAGCGGAT TTGAACGTTGCGAAG CAACGGCCCGGAGGG TGGCGGGCAGGACGC CCGCCATAAACTGCC AGGAATTAATTCCCC 4 8 6 0 
AGGCATCAAATAAAA CGAAAGGCTCAGTCG AAAGACTGGGCCTTT CGTTTTATCTGTTGT TTGTCGGTGAACGCT CTCCTGAGTAGGACA 4 9 5 0 
AATCCGCCGGGAGCG GATTTGAACGTTGCG AAGCAACGGCCCGGA GGGTGGCGGGCAGGA CGCCCGCCATAAACT GCCAGGAATTAATTC 5 0 4 0 
CCCAGGCATCAAATA AAACGAAAGGCTCAG TCGAAAGACTGGGCC TTTCGTTTTATCTGT TGTTTGTCGGTGAAC GCTCTCCTGAGTAGG 5 1 3 0 
ACAAATCCGCCGGGA GCGGATTTGAACGTT GCGAAGCAACGGCCC GGAGGGTGGCGGGCA GGACGCCCGCCATAA ACTGCCAGGAATTAA 5 2 2 0 
TTCCCCAGGCATCAA ATAAAACGAAAGGCT CAGTCGAAAGACTGG GCCTTTCGTTTTATC TGTTGTTTGTCGGTG AACGCTCTCCTGAGT 5 3 1 0 
AGGACAAATCCGCCG GGAGCGGATTTGAAC GTTGCGAAGCAACGG CCCGGAGGGTGGCGG GCAGGACGCCCGCCA TAAACTGCCAGGAAT 5 4 0 0 
TAATTCCCCAGGCAT CAAATAAAACGAAAG GCTCAGTCGAAAGAC TGGGCCTTTCGTTTT ATCTGTTGTTTGTCG GTGAACGCTCTCCTG 5 4 9 0 
AGTAGGACAAATCCG CCGGGAGCGGATTTG AACGTTGCGAAGCAA CGGCCCGGAGGGTGG CGGGCAGGACGCCCG CCATAAACTGCCAGG 5 5 8 0 
AATTGGGGATCGGAA TTAATTCCCGGTTTA AACCGGGGATCTCGA TCCCGCGAAATTAAT ACGACTCACTATAGG GGAATTGTGAGCGGA 5 6 7 0 
M F N T Y Q H L L P E T 
TAACAATTCCCCTCT AGAAATAATTTTGTT TAACTTTAAGAAGGA GATATACATATGTTC AATACCTATCAGCAC TTGTTGCCAGAGACC 5 7 6 0 
V R H L P D V K K Q L A M V R P G L S M L S I F I C L K G T 
GTCCGCCATCTGCCA GATGTGAAGAAGCAG CTGGCGATGGTAAGG CCTGGTCTGAGCATG CTCTCAATCTTCATC TGTCTGAAAGGCACC 5 8 5 0 
K E D L K L Q S T N Y Y V Y F D T D V D K A M E R Y V S M P 
AAGGAGGACCTGAAG CTTCAGTCCACCAAC TACTATGTTTATTTT GACACAGACGTGGAC AAAGCGATGGAGCGC TATGTCTCTATGCCC 5 9 4 0 
K E K A P E H I P L L F I A F P S S K D P T W E E R F P D R 
AAGGAAAAGGCTCCA GAACACATTCCCCTT CTCTTCATTGCCTTC CCATCAAGCAAGGAT CCAACCTGGGAGGAG CGATTCCCAGACCGA 6 0 3 0 
S T M T A L V P M A F E W F E E W Q E E P K G K R G V D Y E 
TCCACAATGACTGCG CTGGTACCCATGGCC TTTGAATGGTTCGAG GAGTGGCAGGAGGAG CCAAAGGGCAAGCGT GGTGTTGACTATGAG 6 1 2 0 
T L K N A F V E A S M S V I M E L F P R L E G K V E S V T G 
ACCCTCAAAAATGCC TTCGTGGAAGCCTCT ATGTCGGTGATCATG GAACTGTTCCCACGG CTGGAGGGCAAGGTG GAGAGTGTGACTGGA 6 2 1 0 
G S P L T N Q Y Y L A A P R G A T Y G A D H D L A R L H P H 
GGGTCACCACTGACC AACCAGTACTATCTG GCTGCACCCCGAGGA GCTACCTATGGAGCT GACCATGACTTGGCT CGGCTGCATCCTCAT 6 3 0 0 
A M A S I R A Q T P I P N L Y L T G Q D I F T C G L M G A L 
GCAATGGCTTCCATA AGAGCCCAAACCCCC ATCCCCAACCTCTAC CTGACAGGCCAAGAT ATCTTCACCTGTGGG CTGATGGGGGCCCTG 6 3 9 0 
Q G A L I i C S S A I L K R N L Y S D L Q A L G S K V K A Q K 
CAGGGGGCCTTGCTG TGCAGCAGTGCCATC CTGAAACGGAACTTG TACTCAGATCTGCAG GCTCTTGGCTCAAAG GTCAAGGCACAAAAG 6 4 8 0 
K J C M C G R A C F A K G T N V L M A D G S I E C I E N I E V 
AAGAAGATGTGCGGA AGAGCCTGCTTTGCC AAGGGTACCAATGTT TTAATGGCGGATGGG TCTATTGAATGTATT GAAAACATTGAGGTT 6 5 7 0 
G N K V M G K D G R P R E V I K L P R G R E T M Y S V V Q K 
GGTAATAAGGTCATG GGTAAAGATGGCAGA CCTCGTGAGGTAATT AAATTGCCCAGAGGA AGAGAAACTATGTAC AGCGTCGTGCAGAAA 6 6 6 0 
S Q H R A H K S D S S R E V P E L L K F T C N A T H E L V V 
AGTCAGCACAGAGCC CACAAAAGTGACTCA AGTCGTGAAGTGCCA GAATTACTCAAGTTT ACGTGTAATGCGACC CATGAGTTGGTTGTT 6 7 5 0 
R T P R S V R R L S R T I K G V E Y F E V I T F E M G Q K K 
AGAACACCTCGTAGT GTCCGCCGTTTGTCT CGTACCATTAAGGGT GTCGAATATTTTGAA GTTATTACTTTTGAG ATGGGCCAAAAGAAA 6 8 4 0 
A P D G R I V E L V K E V S K S Y P I S E G P E R A N E L V 
GCCCCCGACGGTAGA ATTGTTGAGCTTGTC AAGGAAGTTTCAAAG AGCTACCCAATATCT GAGGGGCCTGAGAGA GCCAACGAATTAGTA 6 9 3 0 
E S Y R K A S N K A Y F E W T I E A R D L S L L G S H V R K 
GAATCCTATAGAAAG GCTTCAAATAAAGCT TATTTTGAGTGGACT ATTGAGGCCAGAGAT CTTTCTCTGTTGGGT TCCCATGTTCGTAAA 7 0 2 0 
A T Y Q T Y A P I L Y E N D H F F D Y M Q K S K F H L T I E 
GCTACCTACCAGACT TACGCTCCAATTCTT TATGAGAATGACCAC TTTTTCGACTACATG CAAAAAAGTAAGTTT CATCTCACCATTGAA 7 1 1 0 
G P K V L A y L L G L W I G D G L S D R A T F S V D S R D T 
GGTCCAAAAGTACTT GCTTATTTACTTGGT TTATGGATTGGTGAT GGATTGTCTGACAGG GCAACTTTTTCGGTT GATTCCAGAGATACT 7 2 0 0 
S L M E R V T E Y A E K L N L C A E Y K D R K E P Q V A K T 
TCTTTGATGGAACGT GTTACTGAATATGCT GAAAAGTTGAATTTG TGCGCCGAGTATAAG GACAGAAAAGAACCA CAAGTTGCCAAAACT 7 2 9 0 
V N L Y S K V V R G N G I R N N L N T E N P L W D A I V G L 
GTTAATTTGTACTCT AAAGTTGTCAGAGGT AATGGTATTCGCAAT AATCTTAATACTGAG AATCCATTATGGGAC GCTATTGTTGGCTTA 7 3 8 0 
G F L K D G V K N I P S F L S T D N I G T R E T F L A G L I 
GGATTCTTGAAGGAC GGTGTCAAAAATATT CCTTCTTTCTTGTCT ACGGACAATATCGGT ACTCGTGAAACATTT CTTGCTGGTCTAATT 7 4 7 0 
D S D G Y V T D E H G I K A T I K T I H T S V R D G L V S L 
GATTCTGATGGCTAT GTTACTGATGAGCAT GGTATTAAAGCAACA ATAAAGACAATTCAT ACTTCTGTCAGAGAT GGTTTGGTTTCCCTT 7 5 6 0 
A R S L G L V V S V N A E P A K V D M N V T K H K I S Y A I 
GCTCGTTCTTTAGGC TTAGTAGTCTCGGTT AACGCAGAACCTGCT AAGGTTGACATGAAT GTCACCAAACATAAA ATTAGTTATGCTATT 7 6 5 0 
y M S G G D V L L N V L S K C A G S K K F R P A P A A A F A 
TATATGTCTGGTGGA GATGTTTTGCTTAAC GTTCTTTCGAAGTGT GCCGGCTCTAAAAAA TTCAGGCCTGCTCCC GCCGCTGCTTTTGCA 7 7 4 0 
R E C R G F Y F E L Q E L K E D D Y Y G I T L S D D S D H Q 
CGTGAGTGCCGCGGA TTTTATTTCGAGTTA CAAGAATTGAAGGAA GACGATTATTATGGG ATTACTTTATCTGAT GATTCTGATCATCAG 7 8 3 0 
102 
F L L G S Q V V V H A C G G L T G L N S G L T T N P G V S A 
TTTTTGCTTGGATCC CAGGTTGTCGTCCAT GCATGCGGTGGCCTG ACCGGTCTGAACTCA GGCCTCACGACAAAT CCTGGTGTATCCGCT 7 9 2 0 
W Q V N T A Y T A G Q L V T Y N G K T Y K C L Q P H T S L A 
TGGCAGGTCAACACA GCTTATACTGCGGGA CAATTGGTCACATAT AACGGCAAGACGTAT AAATGTTTGCAGCCC CACACCTCCTTGGCA 8 0 1 0 
G W E P S N V P A L W Q L Q 
GGATGGGAACCATCC AACGTTCCTGCCTTG TGGCAGCTT|CAA|TGA CTGCAGGAAGGGGAT CCGGCTGCTAACAAA GCCCGAAAGGAAGCT 8 1 0 0 
GAGTTGGCTGCTGCC ACCGCTGAGCAATAA CTAGCATAACCCCTT GGGGCCTCTAAACGG GTCTTGAGGGGTTTT TTGCTGAAAGGAGGA 8 1 9 0 
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